[{"text": "With 38% stake, Bravura Solutions Limited (ASX:BVS) seems to have captured institutional investors' interest editorial-team@simplywallst.com (Simply Wall St) Fri, Jan 24, 2025, 11:02 PM 4 min read In This Article: BVSFF Key Insights Given the large stake in the stock by institutions, Bravura Solutions' stock price might be vulnerable to their trading decisions The top 7 shareholders own 53% of the company Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company Every investor in Bravura Solutions Limited ( ASX:BVS ) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are institutions with 38% ownership. Put another way, the group faces the maximum upside potential (or downside risk). Since institutional have access to huge amounts of capital, their market moves tend to receive a lot of scrutiny by retail or individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute. Let's delve deeper into each type of owner of Bravura Solutions, beginning with the chart below. View our latest analysis for Bravura Solutions ASX:BVS Ownership Breakdown January 24th 2025 What Does The Institutional Ownership Tell Us About Bravura Solutions? Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. Bravura Solutions already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Bravura Solutions, (below). Of course, keep in mind that there are other factors to consider, too. ASX:BVS Earnings and Revenue Growth January 24th 2025 We note that hedge funds don't have a meaningful investment in Bravura Solutions. Pinetree Capital Ltd. is currently the company's largest shareholder with 22% of shares outstanding. With 7.0% and 5.4% of the shares outstanding respectively, Rorema Beheer B.V. and Australian Ethical Investment Limited are the second and third largest shareholders. On further inspection, we found that more than half the company's shares are owned by the top 7 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones. While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future. Story Continues Insider Ownership Of Bravura Solutions While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. We can report that insiders do own shares in Bravura Solutions Limited. As individuals, the insiders collectively own AU$49m worth of the AU$964m company. This shows at least some alignment. You can click here to see if those insiders have been buying or selling. General Public Ownership With a 33% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Bravura Solutions. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. Private Equity Ownership With an ownership of 22%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public. Next Steps: While it is well worth considering the different groups that own a company, there are other factors that are even more important. Many find it useful to take an in depth look at how a company has performed in the past. You can access this detailed graph of past earnings, revenue and cash flow . Ultimately the future is most important . You can access this free report on analyst forecasts for the company . NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BVS", "date": "2025-01-24T23:02:38", "sentiment": {"score": -0.24758529663085938, "confidence": 0.32753872871398926, "probabilities": {"positive": 0.07995343208312988, "negative": 0.32753872871398926, "neutral": 0.5925078988075256}}, "embedding": [0.06398431211709976, -0.19376324117183685, -0.06592690199613571, 0.009054048918187618, -0.051405180245637894, -0.0052685001865029335, -0.0035270554944872856, 0.05582258105278015, 0.14196521043777466, 0.023046094924211502, -0.10319854319095612, 0.04739048331975937, 0.007494528777897358, 0.037785276770591736, -0.07524566352367401, -0.026331381872296333, 0.0017820089124143124, -0.0839724987745285, -0.08062337338924408, 0.16604220867156982, -0.06383377313613892, -0.20370954275131226, -0.0026643071323633194, 0.09760434180498123, 0.025996359065175056, -0.09360739588737488, -0.06647104769945145, -0.10728368908166885, -0.11253777891397476, -0.13223308324813843, -0.030914653092622757, 0.08771213889122009, 0.15857365727424622, -0.055546410381793976, -0.042829375714063644, 0.03830108419060707, -0.0586429163813591, 0.019013499841094017, 0.017705310136079788, -0.0013248184695839882, -0.002453114604577422, 0.04402773827314377, -0.07340424507856369, -0.05190617963671684, 0.1009792909026146, -0.07852679491043091, 0.17647570371627808, 0.03636320307850838, 0.01755298487842083, 0.04522200673818588, -0.12029457092285156, -0.03045406937599182, 0.06967303156852722, -0.06728051602840424, -0.0724346712231636, 0.051205530762672424, -0.11298598349094391, -0.01218386273831129, 0.11249609291553497, 0.07680384814739227, 0.18412676453590393, 0.07123471051454544, -0.02527664229273796, -0.04312993586063385, 0.15382659435272217, 0.015306632034480572, -0.0006038490682840347, 0.16325366497039795, -0.10957421362400055, 0.025951437652111053, 0.18433907628059387, -0.11721260100603104, -0.1357543021440506, 0.040743760764598846, -0.020704325288534164, 0.07386833429336548, 0.05271972715854645, 0.0797680988907814, 0.044002823531627655, -0.13698811829090118, 0.10491465032100677, 0.018275249749422073, -0.1005098819732666, 0.0352649986743927, -0.022981639951467514, 0.02868802845478058, 0.14422403275966644, -0.003123081289231777, 0.08504891395568848, 0.0058122542686760426, 0.14687642455101013, -0.026303395628929138, 0.05496622249484062, -0.14031021296977997, 0.1815139204263687, 0.04407981410622597, -0.015211733058094978, 0.0002928059548139572, 0.016845040023326874, -0.018714595586061478, 0.0006229672580957413, -0.08179974555969238, -0.08236443996429443, -0.04659126698970795, -0.05659646913409233, -0.06668691337108612, 0.05361546576023102, -0.08416092395782471, 0.16727004945278168, -0.023036539554595947, -0.09310231357812881, 0.08655226975679398, -0.09768030047416687, 0.006292312406003475, -0.023717287927865982, 0.0770745500922203, -0.06609848141670227, 0.04434245079755783, 0.07589676976203918, -0.06824475526809692, 0.10872824490070343, 0.056125130504369736, 0.06606774032115936, -0.06041182577610016, 0.06643074750900269, 0.1086222231388092, -0.16174067556858063, 1.4891691408674608e-32, -0.016323430463671684, 0.14493387937545776, -0.05401264876127243, -0.03691559284925461, -0.11989408731460571, -0.0319780558347702, 0.00885006133466959, -0.022181816399097443, -0.14084601402282715, 0.026303399354219437, -0.1469491571187973, 0.11003999412059784, -0.010911267250776291, -0.12494394183158875, 0.11232000589370728, -0.02627922035753727, -0.0577269047498703, 0.053805943578481674, -0.03489363193511963, -0.0560225248336792, 0.004614200908690691, 0.19729863107204437, -0.09010997414588928, -0.005016065202653408, 0.010115338489413261, -0.21545420587062836, -0.04782305657863617, -0.052936065942049026, -0.03644922003149986, 0.03852136433124542, 0.1436641812324524, 0.06426665186882019, -0.0685005933046341, -0.10650474578142166, 0.0018798410892486572, -0.04532315582036972, -0.13122713565826416, -0.04616135358810425, -0.010211240500211716, -0.017048567533493042, -0.05513150617480278, 0.08897839486598969, -0.11584343761205673, 0.09239087998867035, 0.04683585464954376, -0.08297029882669449, -0.06243317574262619, -0.005141568370163441, 0.03705718368291855, -0.0251211728900671, -0.06276990473270416, 0.07802063971757889, 0.001857197843492031, -0.07217441499233246, 0.0628669485449791, 0.0009853120427578688, 0.06030355766415596, -0.0301048643887043, 0.04484454542398453, 0.013698182068765163, 0.037167757749557495, 0.003422764129936695, -0.08368049561977386, -0.06593054533004761, -0.1047794371843338, 0.2121412456035614, 0.07588379085063934, 0.13871638476848602, -0.007569645531475544, -0.03452835977077484, 0.009401513263583183, -0.004281444940716028, 0.00821344181895256, -0.1412200629711151, -0.02051527239382267, -0.049036718904972076, -0.03751850500702858, 0.16232982277870178, 0.07801695913076401, -0.05823889747262001, -0.05238383635878563, -0.0029907026328146458, 0.12974613904953003, -0.004236388485878706, -0.001455109566450119, 0.07470561563968658, 0.08840072154998779, -0.0648476630449295, -0.11353644728660583, -0.022659730166196823, 0.13565504550933838, -0.08171844482421875, 0.02472008764743805, 0.11190253496170044, -0.07537341862916946, -1.009780504083054e-32, -0.10651105642318726, -0.1031208336353302, -0.007533755153417587, 0.022762659937143326, -0.025865085422992706, -0.05617532134056091, 0.12344597280025482, -0.09547941386699677, -0.0847664624452591, -0.16689909994602203, -0.03410308063030243, 0.021554891020059586, -0.03670598194003105, 0.14022068679332733, -0.0634324848651886, -0.020395584404468536, 0.18220730125904083, -0.10993713140487671, -0.05471144616603851, -0.08836695551872253, -0.03033595159649849, 0.07659401744604111, 0.08105956017971039, 0.11009180545806885, -0.007418829947710037, 0.057670190930366516, 0.008133583702147007, 0.04841490089893341, 0.09523828327655792, -0.05493651330471039, 0.011087482795119286, 0.043444935232400894, -0.19134798645973206, 0.007759306579828262, -0.008021733723580837, -0.026709964498877525, -0.03785866126418114, -0.07471034675836563, -0.08230634778738022, -0.004833119921386242, 0.056228071451187134, 0.08152437955141068, -0.032516997307538986, -0.07884648442268372, 0.08810155093669891, 0.054103732109069824, 0.10438837110996246, 0.029069246724247932, 0.1660585254430771, 0.1146235242486, 0.06893673539161682, -0.06164575740695, 0.1139170229434967, 0.15276062488555908, 0.00208169873803854, -0.015113950707018375, -0.0010266117751598358, 0.050404563546180725, -0.015204898081719875, 0.05379869416356087, 0.0645349845290184, 0.1424204409122467, 0.08303318172693253, 0.15125501155853271, -0.011933259665966034, 0.12898318469524384, -0.08121669292449951, -0.026709027588367462, -0.0642995834350586, -0.1820281445980072, 0.03548477590084076, -0.22409126162528992, 0.016042957082390785, -0.09453871846199036, -0.11902254819869995, 0.2507164776325226, -0.011576227843761444, -0.16878288984298706, -0.08079598844051361, -0.06127429008483887, -0.06942925602197647, 0.10299672186374664, 0.013915582560002804, 0.021956948563456535, -0.051158078014850616, 0.13384008407592773, 0.0371476449072361, -0.08978584408760071, 0.06521862745285034, 0.04144135117530823, -0.05822594463825226, -0.1339510977268219, 0.07296225428581238, -0.06671828031539917, 0.09567666053771973, -9.97044224959609e-08, -0.010801916942000389, 0.007290630601346493, 0.016282491385936737, -0.03823953866958618, 0.09742709994316101, -0.1404518187046051, 0.019742518663406372, -0.010546120814979076, -0.017494190484285355, 0.17514824867248535, 0.08344137668609619, -0.0012140159960836172, -0.17281970381736755, -0.0588345006108284, -0.057519398629665375, 0.06427979469299316, -0.08809539675712585, 0.0030509103089571, -0.0916917473077774, -0.09240476042032242, 0.1902841329574585, 0.03435565158724785, 0.06696643680334091, -0.04092828929424286, 0.008894090540707111, 0.0031208693981170654, -0.12933482229709625, -0.053996890783309937, 0.1297663301229477, 0.032124631106853485, 0.12661853432655334, -0.050304267555475235, 0.1803068220615387, 0.03072541579604149, 0.0964280217885971, 0.0643676146864891, 0.03388906270265579, 0.17792104184627533, 0.07168366014957428, 0.14699730277061462, -0.001999050844460726, -0.11639950424432755, 0.0629226416349411, -0.007022826001048088, -0.04084588214755058, -0.06779780983924866, -0.09658928960561752, 0.036344170570373535, 0.1347636878490448, -0.14459079504013062, 0.07755288481712341, -0.11834622919559479, -0.029084237292408943, 0.16821277141571045, 0.01188611425459385, -0.06203518807888031, -0.052725374698638916, 0.05684161186218262, -0.05064772069454193, -0.023351605981588364, 0.02827088162302971, -0.20503881573677063, 0.03717714548110962, 0.14704042673110962], "changes": {"1wk": 6.480564202488168}}, {"text": "Saverglass launches new glass bottles in North America Saverglass designs and produces glass bottles for the spirits and wine markets. Credit: il21 via Shutterstock. \u00b7 Packaging Gateway \u00b7 il21 via Shutterstock. GlobalData Thu, Jan 16, 2025, 3:20 PM 1 min read Saverglass, a glass bottle manufacturer, has introduced its new premium wine glass bottles specifically designed for the North American market. The Roble Burgundy bottle with a Carr\u00e9e finish, as well as two new lines, the Stella Collection and Diamond Collection, are now available in the US and Canada. The newly unveiled Roble glass bottle, weighing 500g, is available in four distinct finishes: the traditional 29.5 Cetie, the modern 30 hybrid Carr\u00e9e, and a unique 32 Carr\u00e9e thick finish. Notably, the 32 Carr\u00e9e finish is offered at the same price as the Cetie and hybrid-Carr\u00e9e 30 finishes, ensuring customers receive a high-quality glass bottle without additional costs. The Roble collection also introduces the Roble BVS finish, tailored for screwcap closures, adding versatility and a premium touch to the range. Additionally, the Diamond Collection presents the Antik bottle, which features three light-reflecting bases that mimic diamond facets. The Stella Collection includes the Origin, a lightweight and shorter Burgundy bottle ideal for contemporary and elegant branding, and the Reset and Fairy Bell, two distinctive shapes perfect for a broad spectrum of wines, including Ros\u00e9. Moreover, all new designs are also available in white flint glass, providing further options for wine producers. Saverglass designs and produces glass bottles for the spirits and wine markets. \"Saverglass launches new glass bottles in North America\" was originally created and published by Packaging Gateway , a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BVS", "date": "2025-01-16T15:20:38", "sentiment": {"score": 0.04009995423257351, "confidence": 0.05288786068558693, "probabilities": {"positive": 0.05288786068558693, "negative": 0.01278790645301342, "neutral": 0.9343242645263672}}, "embedding": [-0.063370481133461, 0.01761741377413273, -0.08081742376089096, -0.08649186044931412, 0.08545510470867157, 0.10278414934873581, -0.006737946067005396, 0.04068934917449951, 0.009557430632412434, -0.0751815065741539, -0.1615794152021408, -0.017557471990585327, -0.05489563196897507, -0.05268247425556183, 0.03291686251759529, 0.01078039314597845, -0.0030545482877641916, 0.009554263204336166, -0.03813045099377632, 0.10698235780000687, 0.13630326092243195, -0.1261955052614212, 0.06393922120332718, 0.14913734793663025, -0.06377731263637543, 0.016059117391705513, -0.04511600360274315, 0.023213742300868034, -0.06751532852649689, -0.12084513157606125, 0.08807849138975143, 0.07521989941596985, -0.0030938026029616594, -0.09144746512174606, 0.04865352809429169, -0.11595917493104935, -0.05049515515565872, 0.06564025580883026, -0.010703790932893753, -0.014660540036857128, -0.008883100934326649, -0.054946571588516235, -0.1891024112701416, 0.22345098853111267, -0.07744918018579483, 0.04066505283117294, -0.012740169651806355, 0.19269880652427673, -0.03612208366394043, -0.03531074523925781, -0.02957194857299328, -0.06150450557470322, -0.09268475323915482, -0.20094484090805054, 0.14098195731639862, 0.07203278690576553, 0.05725238472223282, -0.0732395201921463, 0.08892262727022171, 0.039375074207782745, 0.1535230129957199, -0.00542069785296917, -0.09440025687217712, 0.04366050660610199, -0.028102047741413116, 0.07669030129909515, -0.06825978308916092, 0.09199117869138718, 0.030863432213664055, -0.11979177594184875, -0.013710306957364082, -0.06787174195051193, 0.01947520114481449, 0.1914958953857422, -0.009870752692222595, 0.011231417767703533, 0.2024947553873062, -0.044327620416879654, -0.19334764778614044, 0.10400991141796112, -0.10486631840467453, 0.03317737951874733, -0.06035379320383072, -0.005742181092500687, 0.03883243352174759, -0.035013239830732346, 0.04421493783593178, -0.02366752177476883, 0.020647162571549416, -0.05115800350904465, -0.037624046206474304, 0.14334934949874878, -0.18858391046524048, -0.08456512540578842, -0.02545762062072754, -0.07830166816711426, 0.12029343843460083, 0.048366814851760864, 0.031640324741601944, 0.06293690949678421, 0.0940861850976944, -0.04033013805747032, 0.017738059163093567, -0.12445362657308578, -0.025138532742857933, -0.16111111640930176, 0.06042605638504028, 0.00036527978954836726, 0.07021290808916092, 0.053088512271642685, -0.12317401170730591, 0.057346198707818985, -0.07526068389415741, -0.05897265300154686, -0.11931002140045166, -0.039444275200366974, -0.14055857062339783, 0.013748086988925934, 0.15175198018550873, -0.06667788326740265, 0.06268084794282913, 0.03160156309604645, 0.16065897047519684, -0.056506674736738205, -0.08054248988628387, -0.10189800709486008, 0.024464182555675507, 8.146853964502083e-33, -0.036217089742422104, 0.0045163799077272415, -0.016958588734269142, 0.04199181869626045, 0.05426274240016937, 0.00363864004611969, -0.02165696769952774, 0.03139097988605499, -0.07985889911651611, -0.004772768821567297, 0.010687058791518211, -0.048844825476408005, -0.12356396019458771, 0.15451346337795258, 0.10528209805488586, -0.08104101568460464, 0.00811619870364666, -0.022752394899725914, -0.15135729312896729, -0.09134240448474884, -0.06515496969223022, 0.07087906450033188, -0.015631821006536484, 0.197488471865654, -0.1321788728237152, 0.06348465383052826, 0.07488075643777847, 0.05977438762784004, 0.04905739799141884, 0.10533568263053894, -0.018425744026899338, 0.03311151638627052, 0.14189156889915466, 0.05258839949965477, -0.07502122968435287, -0.01313068252056837, -0.15492336452007294, -0.14849135279655457, 0.051651012152433395, -0.10754936188459396, -0.060202810913324356, 0.1524355411529541, 0.13022516667842865, 0.11554057896137238, 0.007423642557114363, -0.05990762636065483, -0.09137236326932907, 0.09140431135892868, -0.06313168257474899, -0.0035575490910559893, -0.05632873252034187, -0.036613136529922485, -0.0931209996342659, 0.15409009158611298, -0.1911953091621399, -0.0315609872341156, -0.019870294257998466, 0.006980858743190765, 0.062287189066410065, -0.2266857773065567, 0.037065036594867706, 0.12515166401863098, 0.03485250845551491, 0.026069141924381256, 0.024354882538318634, 0.25477856397628784, -0.026641057804226875, 0.02462051250040531, -0.016379941254854202, -0.09920334070920944, -0.08601542562246323, 0.02403593808412552, 0.015577820129692554, 0.018485598266124725, 0.11442875117063522, -0.026593387126922607, 0.07108715176582336, 0.05044020712375641, 0.09553968906402588, -0.02921574003994465, -0.08594978600740433, 0.03860079497098923, -0.04861332103610039, -0.20966863632202148, -0.15332454442977905, -0.11767081916332245, 0.014450330287218094, -0.004647464491426945, 0.07012522220611572, -0.029595356434583664, 0.05253548175096512, -0.14580638706684113, -0.03509093075990677, 0.017092041671276093, -0.021516934037208557, -8.332154485861893e-33, 0.16941289603710175, -0.1502603143453598, 0.11139502376317978, 0.07037915289402008, 0.17166809737682343, 0.04276357963681221, -0.03648298606276512, -0.0476880706846714, -0.03897750750184059, -0.2813394069671631, 0.008134542964398861, 0.007924194447696209, -0.04653950780630112, 0.08903061598539352, -0.023020360618829727, 0.05021835118532181, 0.1451559066772461, 0.039742764085531235, -0.07946892082691193, -0.006632152944803238, 0.0799202024936676, 0.1593015193939209, -0.09857438504695892, -0.11985126882791519, -0.08407202363014221, -0.04655677452683449, -0.014991040341556072, 0.022188391536474228, 0.06598962098360062, -0.056622542440891266, 0.117265485227108, 0.06105663627386093, -0.034007102251052856, 0.09043769538402557, -0.18055151402950287, -0.040141958743333817, 0.012440021149814129, -0.14451242983341217, -0.01720878854393959, 0.13272149860858917, 0.10373062640428543, -0.12278713285923004, -0.04860205575823784, 0.014644613489508629, 0.034040119498968124, -0.022722026333212852, -0.03385574370622635, -0.04408329725265503, 0.1561218649148941, 0.05728069692850113, 0.10367298126220703, 0.026979325339198112, -0.06086882948875427, 0.09949912875890732, 0.0015141693875193596, -0.038896799087524414, 0.03126037120819092, -0.019840609282255173, -0.019325129687786102, 0.048700302839279175, 0.0312625914812088, 0.18422898650169373, 0.06825955957174301, -0.12245624512434006, 0.040231067687273026, 0.017571544274687767, 0.038136519491672516, 0.14089077711105347, -0.007894509471952915, -0.02829260379076004, 0.0037544765509665012, 0.04305855929851532, -0.058292683213949203, 0.03613220527768135, -0.02881280519068241, -0.06440407037734985, -0.12702827155590057, -0.049404848366975784, -0.12351147830486298, 0.05418648198246956, -0.16681750118732452, 0.014206068590283394, 0.06659351289272308, 0.2768034338951111, 0.07250406593084335, -0.16682682931423187, -0.03588210046291351, -0.1311393529176712, -0.08432488143444061, 0.05889475345611572, -0.03834867849946022, 0.14394819736480713, -0.05409521609544754, 0.1739271879196167, 0.118035688996315, -9.946800361149144e-08, 0.05481816455721855, 0.12450502067804337, 0.026501426473259926, 0.10469666868448257, 0.010137693956494331, -0.08081652224063873, -0.0057427166029810905, 0.07992538064718246, -0.0546390675008297, -0.016344407573342323, 0.05050558224320412, 0.05937165394425392, -0.0680646151304245, -0.12774202227592468, -0.11427018791437149, 0.0006743324920535088, 0.017456358298659325, -0.02141169272363186, -0.019222021102905273, -0.01627202145755291, 0.11031216382980347, -0.05038762465119362, 0.18309541046619415, -0.06859639286994934, -0.11877253651618958, -0.009102536365389824, -0.03033752366900444, 0.043576765805482864, 0.11649943143129349, -0.004216846078634262, 0.06494490802288055, 0.04391232877969742, 0.14856678247451782, 0.13510534167289734, 0.025559209287166595, 0.11467134952545166, -0.17746485769748688, 0.11270996928215027, -0.013678711839020252, 0.0688851848244667, 0.08869663625955582, -0.3928481638431549, -0.13030511140823364, 0.06682678312063217, -0.01832256279885769, -0.025099823251366615, -0.1522362381219864, 0.004538568668067455, -0.09115453064441681, 0.1384650617837906, 0.022447742521762848, 0.08152610063552856, 0.04111922159790993, 0.10041757673025131, 0.038288842886686325, 0.12488475441932678, -0.08168309181928635, -0.08915860205888748, 0.12056604772806168, 0.013786337338387966, 0.12011177837848663, -0.2541505694389343, 0.07199198007583618, 0.08193741738796234], "changes": {"1wk": -0.1978190382642259}}, {"text": "Saverglass Unveils New Premium Wine Glass Bottles for the North American Market Ahead of Unified Wine & Grape Symposium PR Newswire Wed, Jan 15, 2025, 7:30 PM 4 min read Showcasing Innovation, Quality, and Sustainability with Exciting New Additions to its Wine Portfolio FAIRFIELD, Calif. , Jan. 15, 2025 /PRNewswire/ -- Leading premium glass bottle manufacturer Saverglass proudly introduces its newest glass bottle designs, including the highly anticipated Roble Burgundy bottle with a premium Carr\u00e9e finish, along with two new lines\u2014the Stella Collection and the Diamond Collection . The new bottle designs, now available to the US and Canadian markets, enhance the wine experience while upholding Saverglass' commitment to sustainability and premium quality. Roble with the Carr\u00e9e Finish: A Premium Touch for Every Bottle The Roble glass bottle responds to market demand, offering a striking, high-end design. This 500-gram bottle is available in four different finishes: a very traditional 29.5 Cetie, the more modern 30 hybrid Carr\u00e9e, and a unique premium 32 Carr\u00e9e thick finish, which not only enhances the bottle's authenticity but also adds a refined, terroir-inspired touch. The best part? The 32 Carr\u00e9e finish is priced like the Cetie and hybrid-Carr\u00e9e 30 finish, delivering a high-quality glass bottle at no extra cost. The Roble collection also unveils the Roble BVS finish , designed to accommodate screwcap closures. The Roble BVS and Carr\u00e9e finishes are new designs offering enhanced versatility and premium appeal to the collection. Diamond Collection: Refined and Elegant The Diamond Collection introduces an elegant evolution of the Antik bottle, adorned with three light-reflecting bases that emulate the facets of diamonds, embodying the essence of luxury and refinement. This collection is ideal for producers seeking to make a bold, high-impact statement with their wine glass packaging. Stella Collection: Versatile and Beautiful Design The Stella Collection offers a selection of bottles that combine premium design with exceptional functionality. The collection includes Origin , a lightweight and shorter Burgundy bottle, perfect for wine brands looking for a contemporary and elegant presentation, the Reset and Fairy Bell , which are two unique glass bottle shapes, ideal for a wide range of wines, including Ros\u00e9. Additionally, all new designs are also available in white flint glass, providing wine producers with Saverglass bottles renowned for their transparency, brilliance, and luster. Sustainability Meets Premium Quality Saverglass continues to demonstrate that premium quality and environmental responsibility can go hand in hand. Saverglass is proud to offer its customers eco-friendly, high-quality glass bottles that meet wine producer's needs. In 2024, Saverglass received the prestigious Gold Award from Ecovadis, a leading global provider of sustainability ratings. This recognition places Saverglass among the top 5% of companies in the global glass manufacturing industry for their sustainability efforts. Story Continues Join us at the Unified Wine & Grape Symposium in Sacramento, California , from January 28-30, 2025 . Stop by Booth #519 to meet the Saverglass team and discover our latest glass bottle designs. In 2025, Saverglass will have a strong presence at several prestigious wine and spirits trade events, including the North Carolina Wine Growers Symposium and events in New York , Texas , and Oregon . For more information, contact: ton@saverglass.com . For more information about Saverglass, please visit https://www.saverglass.com/en . To stay updated on coming news, follow Saverglass on Instagram @ saverglassofficial , Facebook @ saverglassus and LinkedIn @ saverglass . About Saverglass Inc. Saverglass, a world leader in the design, production, customization, and decoration of high-end glass bottles for the premium and ultra-premium spirits and wine markets, is a privileged partner of the world's leading spirits and wine brands, as well as emerging brands committed to the quality and exclusivity of their packaging. From its seven glass plants and four decoration units benefiting from leading-edge technologies, and thanks to its employees' professionalism, ongoing training, and passion for excellence, Saverglass is committed to its longstanding sustainable development strategy with the objective of reducing its carbon footprint by 50% by 2035. About Orora Saverglass was acquired by the Orora Group in December 2023 . Orora is a global leader in the design, manufacture and decoration of glass bottles and aluminum cans. Listed on the Australian Securities Exchange (ASX), Orora's operations span Australasia, North America , Europe and the UAE. Servicing the global beverage industry, Orora works with some of the best-known drinks brands in the world, with a network of 17 production sites in five countries. www.ororagroup.com . Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/saverglass-unveils-new-premium-wine-glass-bottles-for-the-north-american-market-ahead-of-unified-wine--grape-symposium-302351691.html SOURCE Saverglass View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BVS", "date": "2025-01-15T19:30:00", "sentiment": {"score": 0.18884865939617157, "confidence": 0.19808869063854218, "probabilities": {"positive": 0.19808869063854218, "negative": 0.009240031242370605, "neutral": 0.792671263217926}}, "embedding": [-0.1159043163061142, 0.037861987948417664, -0.05347820371389389, -0.016269121319055557, 0.06058661267161369, 0.12761329114437103, -0.04443487524986267, -0.007449393626302481, 0.04289912432432175, -0.08467172086238861, -0.1491607427597046, 0.018290750682353973, 0.017451146617531776, -0.05187390372157097, 0.015491502359509468, 0.05882003530859947, 0.0071485573425889015, -0.003777936100959778, -0.012297026813030243, 0.15026606619358063, 0.07287164777517319, -0.1430482566356659, 0.05389333888888359, 0.11136598885059357, -0.04463601112365723, 0.03388160839676857, -0.06364782154560089, 0.05461330711841583, -0.11304661631584167, -0.11977885663509369, 0.029222406446933746, 0.13653430342674255, 0.03113362193107605, -0.1017322763800621, -0.03873308748006821, -0.15191778540611267, -0.06656506657600403, 0.044154092669487, -0.07329561561346054, -0.018287286162376404, -0.02666448801755905, -0.030167603865265846, -0.2017093002796173, 0.22799384593963623, -0.05718807876110077, 0.008555557578802109, -0.001001997385174036, 0.14846700429916382, 0.012235167436301708, -0.008298017084598541, -0.007224565371870995, -0.05664513632655144, -0.04603315144777298, -0.22701160609722137, 0.09317673742771149, 0.10289838165044785, 0.03998085856437683, -0.0952707976102829, 0.08338183164596558, -0.07361862808465958, 0.16677430272102356, -0.0418025478720665, -0.09665164351463318, 0.07052820175886154, 0.03795628994703293, 0.010376344434916973, -0.05342642217874527, 0.160435289144516, -0.040462832897901535, -0.029004890471696854, -0.011732595041394234, -0.052092764526605606, -0.03768075257539749, 0.11269153654575348, 0.1170850545167923, 0.08633303642272949, 0.14629079401493073, -0.10926179587841034, -0.21584850549697876, 0.10863765329122543, -0.12031339108943939, 0.014815595000982285, -0.11044777929782867, 0.024203665554523468, 0.025602970272302628, -0.03633933514356613, 0.06646113842725754, -0.11336737871170044, 0.014997494406998158, -0.026366284117102623, -0.0626000240445137, 0.1165497824549675, -0.15239620208740234, -0.13923168182373047, -0.03091919794678688, -0.0330512598156929, 0.09355990588665009, -0.0009038876742124557, 0.027237774804234505, 0.0487695075571537, 0.04079426825046539, 0.01176961325109005, -0.0027201923076063395, -0.1426619291305542, -0.006467005237936974, -0.11637240648269653, 0.05428376421332359, -0.02936619333922863, 0.05369982868432999, 0.03596293553709984, -0.071280837059021, -0.018533742055296898, -0.0756739005446434, -0.09387530386447906, -0.13006921112537384, -0.02079237625002861, -0.1129450649023056, 0.07002628594636917, 0.2057880163192749, -0.04747350886464119, 0.05283762142062187, 0.01903579570353031, 0.09379690140485764, -0.04723526909947395, -0.09988094866275787, -0.09147319942712784, 0.059578947722911835, 8.158769069115605e-33, -0.03843336179852486, 0.013370907865464687, -0.02567290887236595, 0.059083860367536545, 0.06736645847558975, -0.03933306038379669, -0.037201568484306335, 0.0019016014412045479, -0.1412408947944641, -0.009894984774291515, 0.02569657377898693, -0.015751084312796593, -0.11087833344936371, 0.20159798860549927, 0.12720763683319092, -0.09916078299283981, -0.005968910176306963, -0.020484615117311478, -0.16292160749435425, -0.05643875524401665, -0.0767301470041275, 0.0741344690322876, -0.01438751257956028, 0.1717344969511032, -0.11737209558486938, 0.0857267677783966, 0.1956017017364502, 0.09553048759698868, 0.0012049786746501923, 0.07956346124410629, -0.04819110035896301, 0.07030530273914337, 0.13214513659477234, 0.016561497002840042, -0.10540835559368134, 0.018167156726121902, -0.14308348298072815, -0.13268013298511505, 0.09336020797491074, -0.10668254643678665, -0.06544594466686249, 0.09968140721321106, 0.07715824246406555, 0.07815944403409958, -0.016438953578472137, -0.06018737703561783, 0.0198536217212677, 0.10362473130226135, -0.0495854914188385, 0.03687688708305359, -0.05323571711778641, 0.005429277196526527, -0.06950169801712036, 0.15848352015018463, -0.19308756291866302, -0.05055990070104599, 0.017047833651304245, 0.07170173525810242, 0.01569981500506401, -0.15073150396347046, 0.018547285348176956, 0.11173665523529053, 0.024206532165408134, -0.018001195043325424, -0.019991008564829826, 0.3296092748641968, 0.012231038883328438, 0.012940840795636177, 0.04245980083942413, -0.10143863409757614, -0.11802241206169128, 0.04456743597984314, 0.07243816554546356, 0.00878794863820076, 0.10195067524909973, -0.005541367456316948, 0.04372396692633629, -0.005636051297187805, 0.11219123005867004, -0.002698959782719612, -0.15331892669200897, 0.07694603502750397, -0.034597478806972504, -0.1761043667793274, -0.1495254635810852, -0.1251649111509323, 0.03780673071742058, -0.006451880559325218, 0.05779668688774109, -0.04862753674387932, 0.08199380338191986, -0.11769209057092667, 0.011144047603011131, 0.04034583270549774, 0.03565505892038345, -8.410129434255751e-33, 0.1969040185213089, -0.18923258781433105, 0.1396830976009369, 0.05557267740368843, 0.16580532491207123, 0.007273491006344557, -0.0997425839304924, -0.07904598116874695, -0.08033440262079239, -0.22946952283382416, -0.023117853328585625, 0.042398545891046524, -0.0827917754650116, 0.03573447838425636, 0.037439022213220596, 0.07126027345657349, 0.09535446017980576, -0.0693344846367836, -0.09664458781480789, -0.023433726280927658, 0.14812353253364563, 0.21598617732524872, -0.05913824588060379, -0.07126748561859131, -0.06737297773361206, -0.06765499711036682, -0.03176002576947212, 0.022482819855213165, 0.09548148512840271, -0.01173839345574379, 0.11102950572967529, -0.028420982882380486, -0.0754975900053978, 0.0656905472278595, -0.1081598699092865, -0.015816889703273773, -0.005042463541030884, -0.044865742325782776, -0.020082522183656693, 0.1393776834011078, 0.10305476188659668, -0.15977469086647034, -0.10785513371229172, -0.0023834272287786007, 0.11853350698947906, -0.05051841586828232, -0.04987385869026184, -0.10715831816196442, 0.16903409361839294, 0.06527060270309448, 0.06432804465293884, 0.10051567852497101, -0.027951553463935852, 0.1479012370109558, 0.03131647780537605, -0.06848283112049103, 0.012666977941989899, -0.006066459696739912, 0.08917136490345001, 0.03732357174158096, 0.02179892361164093, 0.18021756410598755, 0.06432688236236572, -0.07493692636489868, 0.029633749276399612, 0.0020798309706151485, 0.08407986164093018, 0.06264571845531464, -0.11187781393527985, -0.05108402296900749, -0.05131141468882561, 0.04922661930322647, -0.08313407748937607, 0.029208797961473465, 0.0007142997346818447, -0.02836493030190468, -0.07054438441991806, -0.03731640428304672, -0.11344370245933533, 0.07954336702823639, -0.20893090963363647, -0.04472651332616806, 0.03477812558412552, 0.23737889528274536, 0.09006880223751068, -0.06849563121795654, -0.06733757257461548, -0.13392043113708496, -0.07588906586170197, 0.075937420129776, 0.030114898458123207, 0.13589969277381897, -0.02898409217596054, 0.12010689824819565, 0.09406065195798874, -1.0009357254148199e-07, 0.057789504528045654, 0.15230655670166016, 0.04357492923736572, 0.0711866170167923, 0.036074068397283554, -0.1408187448978424, -0.05039060488343239, 0.08895167708396912, -0.080197274684906, -0.017705459147691727, 0.12425391376018524, -0.019098328426480293, -0.07877394556999207, -0.09302102029323578, -0.07656426727771759, 0.08303327858448029, -0.021189339458942413, 0.013403568416833878, -0.029192104935646057, -0.015687577426433563, 0.07988949120044708, -0.046513453125953674, 0.130937859416008, -0.13086673617362976, -0.18416623771190643, -0.041492849588394165, -0.039880912750959396, 0.010069544427096844, 0.10737498104572296, -0.01617029309272766, 0.09539490193128586, 0.00607139989733696, 0.11479662358760834, 0.05968400090932846, 0.026414528489112854, 0.15726208686828613, -0.1327425241470337, 0.09953335672616959, -0.01860901713371277, 0.15721149742603302, 0.101642906665802, -0.36043262481689453, -0.1466827094554901, 0.06847178936004639, -0.047694891691207886, -0.007742969319224358, -0.11368496716022491, -0.023914363235235214, -0.11355417966842651, 0.10055315494537354, 0.026134394109249115, 0.0052336882799863815, 0.04418635368347168, 0.058252666145563126, -0.008288180455565453, 0.15387344360351562, -0.05193060636520386, -0.06477157771587372, 0.086564801633358, 0.06303761899471283, 0.13859109580516815, -0.2239503562450409, 0.05077064409852028, 0.08097066730260849], "changes": {"1wk": 3.913492409351587}}, {"text": "BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business Zacks Equity Research Fri, Jan 3, 2025, 6:53 PM 3 min read In This Article: BVS RMD BSX CAH Bioventus Inc. BVS announced the completion of its earlier-announced divestiture of the Advanced Rehabilitation business of its subsidiary, Bioness, yesterday. In October 2024, BVS inked a definitive agreement to sell its business to private equity firm, Accelmed Partners (\u201cAccelmed\u201d). Per Bioventus\u2019 management, the divestiture of the Advanced Rehabilitation business is expected to reduce the company\u2019s annual revenues by approximately $50 million and annual adjusted EBITDA by approximately $6 million. The latest divestiture is expected to enable Bioventus to continue improving its focus and execution within its core businesses and enhance liquidity via the receipt of approximately $20 million of net closing proceeds. Likely Trend of BVS Stock Following the News Following the announcement, shares of the company gained nearly 1.2% till yesterday\u2019s closing. Historically, the company has gained a high level of synergies from its various acquisitions and divestitures. We expect market sentiment on the stock to continue to remain positive around this announcement, too. Bioventus currently has a market capitalization of $694.9 million. It has an earnings yield of 4.3%, favorable than the industry\u2019s negative yield. In the last reported quarter, BVS delivered a break-even earnings surprise. Rationale Behind Bioventus\u2019 Divestiture Per Bioventus, the divestiture is expected to enable it to focus on execution within its core, while also enhancing its liquidity. Accelmed\u2019s management believes that Bioness\u2019 Advanced Rehabilitation products are critical for helping patients with stroke and other neuromuscular conditions in their rehabilitation journey. Management also intends to invest in developing and extending the product line to continue improving patients\u2019 lives as it believes that there is a significant opportunity for growth. Industry Prospects in Favor of BVS Per a report by Grand View Research, the global medical rehabilitation services market was estimated at $254.82 billion in 2023 and is expected to witness a CAGR of approximately 6.1% between 2024 and 2030. Factors like the increasing number of patients with neurological, musculoskeletal and cardiologic conditions and the growing incidence of road traffic accidents are likely to drive the market. Given the market potential, the latest divestiture is expected to be a significant milestone for Accelmed and also enable Bioventus to streamline its business. Bioventus\u2019 Notable Development In November 2024, Bioventus reported its third-quarter 2024 results, wherein it recorded a solid uptick in its overall revenues driven by strength in Pain Treatments and Surgical Solutions. Story Continues BVS\u2019 Share Price Performance Shares of the company have gained 110.1% in the past year against the industry\u2019s 7.8% decline. The S&P 500 has returned 26.5% in the same time frame. Zacks Investment Research Image Source: Zacks Investment Research Bioventus\u2019 Zacks Rank & Key Picks Currently, BVS carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader medical space are Cardinal Health, Inc. CAH, ResMed Inc. RMD and Boston Scientific Corporation BSX. Cardinal Health, carrying a Zacks Rank #2 (Buy) at present, has an estimated long-term growth rate of 10.2%. CAH\u2019s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 11.2%. You can see the complete list of today\u2019s Zacks #1 Rank (Strong Buy) stocks here. Cardinal Health\u2019s shares have gained 11.8% compared with the industry\u2019s 0.7% growth in the past year. ResMed, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 14.8%. RMD\u2019s earnings surpassed estimates in each of the trailing four quarters, with the average being 6.4%. ResMed has gained 36.3% compared with the industry\u2019s 9.6% growth in the past year. Boston Scientific, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 13.8%. BSX\u2019s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 8.3%. Boston Scientific\u2019s shares have rallied 53.7% compared with the industry\u2019s 9.6% growth in the past year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX) : Free Stock Analysis Report Cardinal Health, Inc. (CAH) : Free Stock Analysis Report ResMed Inc. (RMD) : Free Stock Analysis Report Bioventus Inc. (BVS) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BVS", "date": "2025-01-03T18:53:00", "sentiment": {"score": 0.930073281750083, "confidence": 0.9475911855697632, "probabilities": {"positive": 0.9475911855697632, "negative": 0.017517903819680214, "neutral": 0.034890927374362946}}, "embedding": [-0.05318089574575424, -0.10277954488992691, 0.035519007593393326, -0.07192651182413101, -0.10718141496181488, 0.062262170016765594, 0.09386692196130753, 0.12712766230106354, 0.11641444265842438, 0.018192214891314507, -0.07837164402008057, 0.06141233444213867, -0.0324869379401207, 0.06282570958137512, -0.07091724872589111, 0.01885182596743107, 0.116095632314682, 0.009886122308671474, -0.21804645657539368, 0.18522730469703674, -0.036492183804512024, 0.03375746309757233, 0.042946744710206985, 0.08416066318750381, -0.07608646899461746, 0.03671739995479584, -0.07704153656959534, -0.039864517748355865, -0.031158654019236565, -0.10224353522062302, 0.0043994588777422905, 0.12512663006782532, 0.12995202839374542, -0.14992165565490723, 0.040707558393478394, 0.06619668751955032, -0.14468196034431458, 0.028690673410892487, -0.07749737799167633, -0.0020565276499837637, -0.08603381365537643, -0.04728071764111519, -0.16156913340091705, -0.018679913133382797, 0.10114437341690063, -0.05439538508653641, 0.03661501407623291, -0.08466138690710068, 0.12547075748443604, 0.0017952523194253445, -0.10752443969249725, -0.12858185172080994, 0.058639951050281525, 0.03925531730055809, -0.10078796744346619, 0.0072770677506923676, -0.13474994897842407, -0.08209474384784698, 0.01184486411511898, -0.07164467126131058, 0.1576078236103058, 0.005733190104365349, 0.10548275709152222, 0.06318013370037079, 0.14466294646263123, 0.0045164600014686584, -0.01719329133629799, -0.03776838257908821, -0.10617029666900635, -0.098698690533638, 0.1085248813033104, -0.19842371344566345, -0.038624297827482224, 0.01957952231168747, -0.14316622912883759, 0.16662494838237762, 0.1538172960281372, 0.07926584780216217, 0.10430951416492462, -0.14933431148529053, 0.09841360151767731, -0.10098759829998016, -0.04854901134967804, 0.09004411846399307, -0.07902514934539795, 0.09969048202037811, 0.042381491512060165, 0.08468236029148102, 0.04244578629732132, 0.05871516838669777, -0.004059480503201485, -0.042555201798677444, 0.05671850964426994, -0.12861782312393188, 0.05077267810702324, 0.052778713405132294, -0.10594232380390167, -0.031188368797302246, 0.10309158265590668, -0.0424090176820755, 0.09462730586528778, 0.12569409608840942, 0.004897697828710079, -0.05204499885439873, -0.05227328836917877, -0.12347089499235153, -0.0031564198434352875, -0.03827463835477829, 0.23078837990760803, 0.028374847024679184, -0.028667977079749107, 0.13395027816295624, -0.1033499538898468, -0.023329652845859528, -0.09817057847976685, 0.28933513164520264, -0.15819168090820312, 0.0031191189773380756, 0.18187642097473145, -0.025968387722969055, 0.1296667903661728, 0.08800989389419556, 0.02225751057267189, -0.1740625947713852, -0.006912209093570709, -0.03342898190021515, -0.027553783729672432, 5.2389645285798796e-33, -0.03381425514817238, -0.056742921471595764, -0.0586845800280571, -0.008677404373884201, -0.023940494284033775, -0.03639842942357063, -0.018297092989087105, -0.05814167112112045, -0.11109328269958496, -0.047005683183670044, -0.190462127327919, 0.09516249597072601, 0.08289512991905212, 0.11028233915567398, 0.0008855783380568027, -0.11746151000261307, -0.13912858068943024, -0.01362316869199276, 0.005057547241449356, -0.021780775859951973, 0.13431011140346527, 0.00852808728814125, -0.05255834013223648, 0.11056499928236008, 0.007077700458467007, -0.09899171441793442, -0.047299113124608994, 0.08812067657709122, 0.09060181677341461, 0.04041541367769241, -0.07339305430650711, 0.07275734096765518, -0.05809778720140457, -0.19642969965934753, -0.09216906875371933, -0.045784320682287216, -0.04456000030040741, -0.1375829577445984, 0.05396861210465431, 0.01660219393670559, -0.030552372336387634, 0.10741941630840302, -0.18277649581432343, -0.18791165947914124, -0.003926568664610386, -0.032248999923467636, 0.00025854073464870453, -0.0813959389925003, 0.03409450501203537, -0.013183115050196648, -0.0926860123872757, 0.058247920125722885, 0.13171738386154175, -0.14441430568695068, -0.05042380839586258, 0.03619140759110451, -0.06507894396781921, -0.04653378203511238, -0.002584946108981967, 0.1502859890460968, 0.03157569468021393, 0.23217976093292236, -0.010279267095029354, 0.05106700211763382, -0.14829599857330322, 0.19317123293876648, 0.16682878136634827, 0.11728741228580475, -0.19003835320472717, 0.015017160214483738, -0.050057552754879, -0.09794048964977264, 0.05757465958595276, -0.10983791947364807, 0.029312724247574806, -0.06040838733315468, -0.0615214928984642, 0.03917365148663521, 0.013580738566815853, 0.0043825251050293446, 0.0071214064955711365, 0.04507110267877579, -0.023971471935510635, 0.1268790066242218, 0.11528223752975464, 0.04400772601366043, -0.016466720029711723, -0.03683380410075188, -0.045018360018730164, -0.06266558170318604, -0.0419137142598629, -0.05874175578355789, -0.09356795251369476, 0.23839423060417175, -0.03002065420150757, -7.621914186939343e-33, -0.09073194861412048, -0.015304877422749996, -0.05077473819255829, 0.013732323423027992, 0.01363118551671505, -0.029484085738658905, 0.10591796040534973, -0.03802816569805145, -0.04612407088279724, -0.028055671602487564, -0.05191655457019806, 0.09638984501361847, -0.08009396493434906, 0.08545476943254471, -0.04226172715425491, 0.05820778012275696, -0.014824967831373215, -0.07760472595691681, -0.024539107456803322, 0.01603529416024685, 0.13054826855659485, 0.2913649082183838, 0.024683652445673943, 0.08395376056432724, 0.07006599754095078, 0.15991559624671936, 0.030669046565890312, 0.09687091410160065, 0.14006611704826355, -0.08399669826030731, -0.06018240004777908, 0.02102827839553356, -0.2076273113489151, 0.09750543534755707, -0.03067515231668949, 0.04358704388141632, 0.003512956202030182, -0.1785934865474701, 0.015756428241729736, -0.08082862198352814, 0.08595022559165955, -0.0005473536439239979, -0.05488334968686104, 0.006993042305111885, 0.16393977403640747, -0.0775938555598259, -0.01907520927488804, -0.10740697383880615, 0.19309045374393463, 0.026601992547512054, -0.020294811576604843, 0.08409525454044342, 0.059400804340839386, 0.10178504139184952, -0.029642727226018906, -0.05182718113064766, 0.03186555951833725, -0.0396638922393322, -0.13246893882751465, -0.021948331966996193, 0.06240929663181305, 0.156524658203125, 0.09721793234348297, 0.007145997136831284, 0.036707255989313126, 0.11905235052108765, 0.06536495685577393, 0.0054170903749763966, -0.1065889447927475, -0.219765305519104, 0.03503037989139557, -0.0688897892832756, -0.04688193276524544, -0.09424184262752533, -0.036077164113521576, 0.2710287570953369, 0.017886720597743988, -0.18092012405395508, -0.10996069759130478, 0.009414352476596832, 0.01994279772043228, 0.012401370331645012, 0.1278708577156067, 0.059302546083927155, -0.005546700209379196, 0.06482726335525513, -0.16096162796020508, -0.15168684720993042, -0.021893121302127838, -0.036260027438402176, -0.16828188300132751, -0.2016056627035141, 0.011156341060996056, 0.07292385399341583, -0.043561313301324844, -1.0071278921941484e-07, 0.03732127696275711, 0.01694674789905548, 0.0783069059252739, -0.024606015533208847, 0.09280461817979813, -0.17149394750595093, -0.050959739834070206, 0.01651023142039776, 0.052120696753263474, 0.13616019487380981, 0.0229263324290514, -0.059443168342113495, -0.18211673200130463, 0.16699662804603577, -0.09021110832691193, 0.0862889438867569, -0.16562137007713318, 0.06346622854471207, -0.02873368188738823, -0.05492214113473892, 0.03759831562638283, -0.03369716554880142, 0.13969963788986206, -0.06378543376922607, 0.06309904903173447, -0.07942727208137512, -0.04101214557886124, -0.04526500031352043, 0.04356652870774269, -0.01716824620962143, 0.023578409105539322, 0.013667725026607513, 0.12308663874864578, 0.054534412920475006, 0.014070451259613037, -0.185054212808609, 0.04116872698068619, 0.1206742450594902, -0.0031913770362734795, 0.10283015668392181, -0.07172594964504242, -0.08144226670265198, 0.061253149062395096, 0.030540747568011284, 0.008211018517613411, -0.07289252430200577, -0.24439719319343567, -0.02651738002896309, 0.06587138772010803, -0.13966436684131622, 0.1419118344783783, -0.135360449552536, 0.014922674745321274, 0.1009385734796524, -0.05529777333140373, 0.13250358402729034, -0.08489132672548294, -0.008757222443819046, -0.06513459980487823, -0.01848837547004223, 0.06613209843635559, -0.22171244025230408, 0.10441651195287704, -0.02136901393532753], "changes": {"1wk": -11.11111009613202, "1mo": 2.298857609567729}}, {"text": "Substantial Rise in the Heart Diseases and Minimally Invasive Procedures is expected to Continue Boosting the Global Coronary Stents Market | Future Market Insights, Inc. Future Market Insights Global and Consulting Pvt. Ltd. Thu, Jan 9, 2025, 3:30 PM 24 min read Future Market Insights Global and Consulting Pvt. Ltd. The Global Coronary Stents Market, valued at USD 35.5 Billion in 2025, Is Projected to Expand at A CAGR of 5.6%, Reaching USD 57.9 Billion by 2035. This Growth Is Propelled by The Rising Prevalence of Coronary Artery Disease (CAD) And Advancements in Stent Technology, Including Biodegradable and Drug-Eluting Stents (DES). NEWARK, Del, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The global Coronary Stents Market , valued at USD 35.5 billion in 2025 , is expected to grow at a robust CAGR of 5.6% , reaching an impressive valuation of USD 57.9 billion by 2035 . This growth is fuelled by the increasing prevalence of cardiovascular diseases, technological advancements in stent manufacturing, and rising demand for minimally invasive procedures. As per the latest Future Market Insights (FMI) analysis, demand for coronary stents and portable coronary stents will rise exponentially in the coming years. An aging population and a rising prevalence of risk factors such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive demand for coronary stents over the forecast period. Added advantages of stenting procedures include substantial improvement of blood flow and prevention of further damage to the heart muscle. It also helps in improving the symptoms of heart disease, such as angina and shortness of breath thereby, reducing the need for coronary bypass surgery. Thus, surgeons prefer stenting, as it is a minimally invasive procedure and post-operative recovery is relatively fast. Coronary stents, small mesh tubes used to restore blood flow in blocked arteries, are playing a critical role in combating coronary artery diseases globally. As healthcare providers increasingly adopt advanced stenting solutions, the market is witnessing steady expansion in both developed and emerging economies. The growing geriatric population is a major driver of market growth, as aging is a significant risk factor for heart diseases. Additionally, enhanced reimbursement policies in various countries and government initiatives aimed at reducing cardiovascular mortality rates are supporting the adoption of coronary stents. By 2035, the market is expected to see a significant shift toward bioresorbable stents , driven by patient preference for temporary implants over permanent solutions. This shift underscores the industry\u2019s move toward innovation and patient-centric care. Which Drivers Underpin Coronary Stents Industry Expansion? Increasing Prevalence of Obesity Likely to Augment the Overall Demand The increasing global aging population is resulting in an increasing patient pool with major cardiovascular diseases. Also, hypertension is emerging as a major public health concern. Aged individuals are more prone to various cardiovascular diseases due to high total serum cholesterol levels. Story Continues Also, obesity is one of the major risk factors responsible for various cardiovascular diseases worldwide. Excessive weight or obesity causes abnormal or excessive accumulation of fats inside the artery lumen that causes several health problems such as coronary heart diseases. Hence, weight loss and obesity management are integral parameters to avoid any kind of cardiovascular disease. According to WHO estimates, each year, 2.8 million deaths across the globe are due to diseases caused by obesity. Thus, the increasing aging and obese population are major factors expected to fuel the growth of the global coronary stents market over the forecast period. Increasing the Number of Stenting Procedures to Push the Sales Added advantages of stenting procedures include substantial improvement of blood flow and prevention of further damage to the heart muscle. Patients suffering from coronary artery blockage are prescribed coronary stenting. Angioplasty is the first line of treatment for patients suffering from acute coronary artery blockages. The number of patients undergoing stenting has been increasing steadily over the last decade. This is due to the emergence of outpatient coronary stenting procedures, which reduces long hospital stays. Further, the usage of bioabsorbable coronary scaffolds in coronary blockage has proven more beneficial over drug-eluting stents. Therefore, an increasing number of cardiologists referring to stenting procedures for patients suffering from CAD is a major factor expected to fuel revenue growth of the coronary stents market in the near future. A Full Report Overview - https://www.futuremarketinsights.com/reports/coronary-stents-market Key Takeaways from Market Study Market Growth: Expected to expand from USD 35.5 billion in 2025 to USD 57.9 billion by 2035 , registering a CAGR of 5.6% . Technological Advancements: Bioresorbable stents are projected to gain market dominance due to patient preference for temporary implants. Aging Population: The increasing prevalence of cardiovascular diseases among older adults is a key growth driver. Regional Expansion: Emerging markets in Asia-Pacific and Latin America are anticipated to witness the fastest growth. Competition: Top players are focusing on R&D and collaborations to deliver cost-effective, advanced stent solutions. \u201cContinuous advancements in coronary stent technologies, coupled with a growing focus on minimally invasive surgeries, are transforming the global coronary stents market. As healthcare systems emphasize patient outcomes and cost-efficiency, manufacturers that invest in innovative stent designs will gain a competitive edge. Additionally, expanding healthcare access in developing regions will significantly boost market growth over the next decade.\u201d Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) Which Factors are limiting the Growth of the Coronary Stents Market? Some of the leading factors limiting the growth of the market include- \u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Availability of Alternative Treatment Methods for Coronary Artery Disease \u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Stringent Regulations for Product Approval \u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Product Failure and Product Recalls \u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Complications Associated With Implantation of Stents \u2022\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Declining Costs of Stents Country-wise Analysis Countries CAGR The USA 1.5% Canada 2.7% Germany 1.6% France 2.4% Italy 2.9% UK 1.9% USA is Dominating the Coronary Stents Market by Growing Prevalence of Coronary Artery Diseases The North American region dominates the coronary stents market share by securing the maximum share during the forecast period. The USA is leading the market size due to the growing number of heart diseases and the rising patient who has CAD during the forecast period. However, the rising adoption of angioplasty among patients is increasing the all-over production of coronary stents, which increases the USA coronary stents market share. According to National Center for Health Statistics, every year, 1 in 4 deaths in the USA are caused due to coronary artery disease (CAD). Approximately 785,000 people in the USA suffer from their first heart attack, and 470,000 suffer from myocardial infarction. In addition, due to changing lifestyle habits, smoking and pollution are increasing the prevalence of coronary artery diseases in the USA in recent years. United Kingdom Market for Coronary Stents Drives by Growing Healthcare Sector The Europe region is capturing a significant market share due to rising government initiatives during the forecast period. The United Kingdom coronary stents market is a prominent leader that contributes a significant share in the region by conducting new initiatives and investing in the healthcare sector during the forecast period. The key manufacturers have increased the United Kingdom coronary stents market size by innovating advanced technology tools to treat patients efficiently in recent years. Moreover, the innovation of the PCI procedure is advanced and most accepted by the healthcare sector in the USA during the forecast period. In addition, this procedure helps to improve survivability and lower chest pain. Korea Coronary Stents Market Boost by Growing Medical Infrastructure The Asia Pacific coronary stents market is one of the fastest-growing regions during the forecast period capturing a high CAGR. Korea is one of the leading countries that increase the coronary stents market growth by growing medical infrastructure during the foreseen time. The manufacturers in Korea have been developing expensive medical devices and innovating as per end-users' demands to acquire maximum output in recent years. Moreover, these players are launching high-value medical consumables devices for the effective treatment of coronary disease patients, which is likely to increase the Korean coronary stents market size. Coronary stent manufacturers in India have evolved by prioritizing innovation and cost-effectiveness to thrive in a competitive industry. Japan Market for Coronary Stents Drives by Rising Awareness Related Coronary Treatment Japan is another country in the Asia Pacific region that also capture the maximum share in the region during the forecast period. Rising awareness related to coronary treatment and the dropping price of coronary stents increased the Japan coronary stents market growth during the forecast period. Moreover, the Growing sedentary lifestyle and growing management of the disease are surging the demand for coronary stents in Japan during the forecast period. In addition, the growing center for cardiac disease and rising coronary stent implantation are flourishing the Japanese coronary stents market growth in recent years. How big is the Opportunity in the USA? The increasing prevalence of coronary artery diseases (CAD) is likely to augment the market growth The increasing prevalence of coronary artery disease is fuelling the demand for interventional cardiology treatment in the USA. Patients suffering from long-term CAD are opting for angioplasty as the first line of treatment. According to National Center for Health Statistics, every year 1 in 4 deaths in the USA are caused due to coronary artery diseases (CAD) and approximately 785,000 people in the USA suffer from their first heart attack and 470,000 suffer from myocardial infarction. This is due to changing lifestyle habits, smoking, pollution, and other factors. This increasing prevalence of coronary artery diseases and higher healthcare expenditure in lower-middle-income countries is projected to boost the growth of the global coronary stents market over the forecast period. How Lucrative Are Opportunities in China? Favorable Government Support for Healthcare Development to Push the Market Positively Increased government investment in healthcare and conducting new initiatives to bring in devices at affordable prices in cost constraint markets such as China are influencing this market as well. For instance, in China, to address inflated pricing and other issues in the delivery of expensive medical supplies, the Chinese government launched a centralized procurement scheme for high-value medical consumables in January 2021. The government aims to use this initiative to skip the associated suppliers and buy the items straight from the manufacturers, lowering the inflated pricing. As a result, the cost of coronary stents has dropped dramatically in China. The average price of coronary stents has been reduced by 93 % since 2019 to grab the national tender. Coronary Stents Market Day by Day Opportunities The Coronary Stents Market offers significant day-to-day opportunities, particularly in emerging markets where healthcare infrastructure is improving. The rising availability of affordable healthcare and increased patient awareness of minimally invasive cardiac procedures are enabling greater market penetration. Moreover, technological innovations such as drug-eluting stents (DES) with enhanced biocompatibility and next-generation bioresorbable stents are opening new avenues for manufacturers to differentiate themselves and capture larger market shares. The market also presents an opportunity for partnerships between hospitals and stent manufacturers to streamline the supply chain and reduce procedural costs. Furthermore, as telemedicine and remote healthcare services grow, access to cardiac care and stent procedures in remote regions is expected to improve dramatically. Component Insights The market is segmented based on product types, with drug-eluting stents (DES) holding the largest market share in 2025 due to their efficacy in preventing restenosis. Bare-metal stents (BMS) and bioresorbable vascular scaffolds (BVS) are other key components, with BVS anticipated to exhibit the fastest growth during the forecast period. Key material segments include metallic stents (cobalt-chromium and platinum-chromium) and polymeric stents , with the latter gaining traction for their biodegradable properties. Competitive Landscape The coronary stent market has achieved significant advancements over the years, driven by innovative product developments, new market players, and evolving regulatory standards. These factors have collectively reshaped the industry and expanded treatment options for coronary artery disease patients. Elunir-Perl Drug-Eluting Stent by Medinol Approved by the FDA in October 2023, the Elunir-Perl represents a cutting-edge solution for coronary artery disease. Designed to offer a safe and effective treatment, this stent incorporates advanced technology to meet patient needs in a variety of clinical scenarios. Xience Sierra by Abbott Laboratories Introduced in 2018 with FDA approval, Xience Sierra is a drug-eluting stent celebrated for its enhanced flexibility and slim profile. Available in small diameters and extended lengths, it is specifically designed to manage complex percutaneous coronary interventions (PCI), thereby improving patient outcomes in challenging cases. Resolute Onyx 2.0mm by Medtronic FDA-approved in 2018, the Resolute Onyx 2.0mm drug-eluting stent is tailored for patients with small coronary arteries. Its precision-focused design addresses the challenges posed by intricate anatomical structures, ensuring more effective treatments for patients with unique cardiovascular needs. These advancements highlight the industry's commitment to innovation and patient-centered solutions, setting the stage for further progress in coronary stent technology. Key Market Players TERUMO CORPORATION Boston Scientific Corporation Medtronic Vascular Concepts B. Braun Melsungen AG BIOTRONIK SE & Co. KG Abbott Laboratories Biosensors International Group, Ltd. HEXACATH STENTYS SA Segmentation By Product: Drug Eluting Stents (DES), Bare Metal Stents (BMS), Bioabsorbable Stents, Self-expanding Stents, Balloon-expandable Stents, etc. By End User: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Other Healthcare Settings. By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer By Region: North America, Latin America, Western Europe, South Asia and Pacific, East Asia, Middle East and Africa. German Translation: Es wird erwartet, dass der globale Markt f\u00fcr Koronarstents, der im Jahr 2025 auf 35,5 Mrd. USD gesch\u00e4tzt wird, mit einer robusten CAGR von 5,6 % wachsen und bis 2035 eine beeindruckende Bewertung von 57,9 Mrd. USD erreichen wird.\u00a0Dieses Wachstum wird durch die zunehmende Pr\u00e4valenz von Herz-Kreislauf-Erkrankungen, technologische Fortschritte bei der Herstellung von Stents und die steigende Nachfrage nach minimalinvasiven Verfahren angeheizt. Laut der neuesten Analyse von Future Market Insights (FMI) wird die Nachfrage nach koronaren Stents und tragbaren koronaren Stents in den kommenden Jahren exponentiell steigen.\u00a0Es wird erwartet, dass eine alternde Bev\u00f6lkerung und eine steigende Pr\u00e4valenz von Risikofaktoren wie Herz-Kreislauf-Erkrankungen (CVDs), komplexen L\u00e4sionen, Diabetes, Fettleibigkeit und anderen die Nachfrage nach koronaren Stents im Prognosezeitraum ankurbeln werden. Zu den weiteren Vorteilen von Stent-Verfahren geh\u00f6ren die erhebliche Verbesserung der Durchblutung und die Vorbeugung weiterer Sch\u00e4den am Herzmuskel.\u00a0Es hilft auch bei der Verbesserung der Symptome von Herzerkrankungen wie Angina pectoris und Kurzatmigkeit, wodurch die Notwendigkeit einer koronaren Bypass-Operation reduziert wird.\u00a0Daher bevorzugen Chirurgen das Stentting, da es sich um ein minimalinvasives Verfahren handelt und die postoperative Genesung relativ schnell erfolgt. Koronare Stents, kleine Netzr\u00f6hrchen, die zur Wiederherstellung des Blutflusses in verstopften Arterien eingesetzt werden, spielen weltweit eine entscheidende Rolle bei der Bek\u00e4mpfung von Erkrankungen der Herzkranzgef\u00e4\u00dfe.\u00a0Da Gesundheitsdienstleister zunehmend fortschrittliche Stent-L\u00f6sungen einsetzen, erlebt der Markt sowohl in den Industrie- als auch in den Schwellenl\u00e4ndern ein stetiges Wachstum. Die wachsende geriatrische Bev\u00f6lkerung ist ein wichtiger Treiber des Marktwachstums, da das Altern ein wesentlicher Risikofaktor f\u00fcr Herzerkrankungen ist.\u00a0Dar\u00fcber hinaus unterst\u00fctzen verbesserte Erstattungsrichtlinien in verschiedenen L\u00e4ndern und Regierungsinitiativen zur Senkung der kardiovaskul\u00e4ren Sterblichkeitsrate die Einf\u00fchrung von koronaren Stents. Bis 2035 wird erwartet, dass sich der Markt hin zu bioresorbierbaren Stents deutlich verlagern wird, angetrieben durch die Pr\u00e4ferenz der Patienten f\u00fcr tempor\u00e4re Implantate gegen\u00fcber dauerhaften L\u00f6sungen.\u00a0Dieser Wandel unterstreicht den Trend der Branche hin zu Innovation und patientenorientierter Versorgung. Welche Treiber treiben die Expansion der Branche f\u00fcr Koronarstents voran? Zunehmende Pr\u00e4valenz von Fettleibigkeit d\u00fcrfte die Gesamtnachfrage erh\u00f6hen Die zunehmende Alterung der Weltbev\u00f6lkerung f\u00fchrt zu einem wachsenden Patientenpool mit schweren Herz-Kreislauf-Erkrankungen.\u00a0Au\u00dferdem entwickelt sich Bluthochdruck zu einem gro\u00dfen Problem f\u00fcr die \u00f6ffentliche Gesundheit.\u00a0\u00c4ltere Menschen sind aufgrund des hohen Gesamtcholesterinspiegels im Serum anf\u00e4lliger f\u00fcr verschiedene Herz-Kreislauf-Erkrankungen. Au\u00dferdem ist Fettleibigkeit einer der Hauptrisikofaktoren, die weltweit f\u00fcr verschiedene Herz-Kreislauf-Erkrankungen verantwortlich sind.\u00a0\u00dcbergewicht oder Fettleibigkeit f\u00fchren zu einer abnormalen oder \u00fcberm\u00e4\u00dfigen Ansammlung von Fetten im Arterienlumen, die verschiedene Gesundheitsprobleme wie koronare Herzkrankheiten verursachen.\u00a0Daher\u00a0sind\u00a0Gewichtsverlust und Adipositas-Management\u00a0integrale Parameter, um jede Art von Herz-Kreislauf-Erkrankungen zu vermeiden. Nach Sch\u00e4tzungen der WHO sind jedes Jahr weltweit 2,8 Millionen Todesf\u00e4lle auf Krankheiten zur\u00fcckzuf\u00fchren, die durch Fettleibigkeit verursacht werden.\u00a0Daher sind die zunehmende Alterung und Fettleibigkeit der Bev\u00f6lkerung wichtige Faktoren, von denen erwartet wird, dass sie das Wachstum des globalen Marktes f\u00fcr Koronarstents im Prognosezeitraum ankurbeln werden. Erh\u00f6hung der Anzahl der Stent-Verfahren, um den Umsatz zu steigern Zu den weiteren Vorteilen von Stent-Verfahren geh\u00f6ren die erhebliche Verbesserung der Durchblutung und die Vorbeugung weiterer Sch\u00e4den am Herzmuskel.\u00a0Patienten, die an einer Verstopfung der Koronararterien leiden, wird ein Koronarstenting verschrieben.\u00a0Die Angioplastie ist die erste Behandlungslinie f\u00fcr Patienten, die an akuten Verschl\u00fcssen der Herzkranzgef\u00e4\u00dfe leiden.\u00a0Die Zahl der Patienten, die sich einem Stenting unterziehen, ist in den letzten zehn Jahren stetig gestiegen.\u00a0Dies ist auf das Aufkommen ambulanter koronarer Stent-Verfahren zur\u00fcckzuf\u00fchren, die lange Krankenhausaufenthalte reduzieren.\u00a0Dar\u00fcber hinaus hat sich die Verwendung von bioresorbierbaren Koronarger\u00fcsten bei der Koronarblockade als vorteilhafter gegen\u00fcber medikamentenfreisetzenden Stents erwiesen. Daher ist eine zunehmende Zahl von Kardiologen, die sich auf Stent-Verfahren f\u00fcr Patienten mit KHK beziehen, ein wichtiger Faktor, der voraussichtlich das Umsatzwachstum des Marktes f\u00fcr koronare Stents in naher Zukunft ankurbeln wird. Wichtige Erkenntnisse aus der Marktstudie Marktwachstum: Es\u00a0wird erwartet, dass es von 35,5 Mrd. USD im Jahr 2025 auf 57,9 Mrd. USD bis 2035 steigen wird, was einer CAGR von 5,6 % entspricht. Technologische Fortschritte: Es wird prognostiziert, dass bioresorbierbare Stents aufgrund der Pr\u00e4ferenz der Patienten f\u00fcr tempor\u00e4re Implantate an Marktdominanz gewinnen werden. Alternde Bev\u00f6lkerung: Die zunehmende Pr\u00e4valenz von Herz-Kreislauf-Erkrankungen bei \u00e4lteren Erwachsenen ist ein wichtiger Wachstumstreiber. Regionale Expansion: Es wird erwartet, dass die Schwellenl\u00e4nder im asiatisch-pazifischen Raum und in Lateinamerika das schnellste Wachstum verzeichnen werden. Wettbewerb: Top-Player konzentrieren sich auf Forschung und Entwicklung sowie Kooperationen, um kosteng\u00fcnstige, fortschrittliche Stent-L\u00f6sungen zu liefern. \"Kontinuierliche Fortschritte in der Technologie f\u00fcr koronare Stents, gepaart mit einem wachsenden Fokus auf minimalinvasive Operationen, ver\u00e4ndern den globalen Markt f\u00fcr koronare Stents.\u00a0Da die Gesundheitssysteme den Schwerpunkt auf Patientenergebnisse und Kosteneffizienz legen, werden Hersteller, die in innovative Stent-Designs investieren, einen Wettbewerbsvorteil erlangen.\u00a0Dar\u00fcber hinaus wird die Ausweitung des Zugangs zur Gesundheitsversorgung in Entwicklungsregionen das Marktwachstum in den n\u00e4chsten zehn Jahren erheblich ankurbeln.\" Sagt\u00a0Sabyasachi Ghosh (Associate Vice President bei Future Market Insights, Inc.) Welche Faktoren begrenzen das Wachstum des Marktes f\u00fcr Koronarstents? Einige der f\u00fchrenden Faktoren, die das Wachstum des Marktes begrenzen, sind: \u2022 Verf\u00fcgbarkeit alternativer Behandlungsmethoden f\u00fcr die koronare Herzkrankheit \u2022 Strenge Vorschriften f\u00fcr die Produktzulassung \u2022 Produktfehler und Produktr\u00fcckrufe \u2022 Komplikationen im Zusammenhang mit der Implantation von Stents \u2022 Sinkende Kosten f\u00fcr Stents Analyse nach L\u00e4ndern L\u00e4nder CAGR The USA 1.5 % Kanada 2.7 % Deutschland 1.6 % Frankreich 2.4 % Italien 2.9 % Vereinigtes K\u00f6nigreich 1.9 % Die USA dominieren den Markt f\u00fcr koronare Stents durch wachsende Pr\u00e4valenz von Erkrankungen der Herzkranzgef\u00e4\u00dfe Die nordamerikanische Region dominiert den Marktanteil der koronaren Stents, indem sie sich im Prognosezeitraum den maximalen Anteil sichert.\u00a0Die USA sind aufgrund der wachsenden Zahl von Herzerkrankungen und der steigenden Zahl von Patienten mit CAD im Prognosezeitraum f\u00fchrend in der Marktgr\u00f6\u00dfe.\u00a0Die zunehmende Akzeptanz der Angioplastie bei Patienten erh\u00f6ht jedoch die Gesamtproduktion von Koronarstents, was den Marktanteil von Koronarstents in den USA erh\u00f6ht. Nach Angaben des National Center for Health Statistics wird jedes Jahr 1 von 4 Todesf\u00e4llen in den USA durch eine koronare Herzkrankheit (KHK) verursacht.\u00a0In den USA erleiden etwa 785.000 Menschen ihren ersten Herzinfarkt, 470.000 einen Herzinfarkt.\u00a0Dar\u00fcber hinaus haben Rauchen und Umweltverschmutzung in den USA in den letzten Jahren aufgrund ver\u00e4nderter Lebensgewohnheiten die Pr\u00e4valenz von Erkrankungen der Herzkranzgef\u00e4\u00dfe erh\u00f6ht. Britischer Markt f\u00fcr Koronarstents wird durch wachsenden Gesundheitssektor angetrieben Die Region Europa erobert aufgrund zunehmender Regierungsinitiativen im Prognosezeitraum einen bedeutenden Marktanteil.\u00a0Das Vereinigte K\u00f6nigreich Der Markt f\u00fcr Koronarstents ist ein bedeutender Marktf\u00fchrer, der durch die Durchf\u00fchrung neuer Initiativen und Investitionen in den Gesundheitssektor im Prognosezeitraum einen bedeutenden Anteil in der Region beitr\u00e4gt.\u00a0Die wichtigsten Hersteller haben das Vereinigte K\u00f6nigreich Marktgr\u00f6\u00dfe f\u00fcr Koronarstents durch die Innovation fortschrittlicher Technologietools zur effizienten Behandlung von Patienten in den letzten Jahren.\u00a0Dar\u00fcber hinaus ist die Innovation des PCI-Verfahrens fortgeschritten und wird im Prognosezeitraum vom Gesundheitswesen in den USA am meisten akzeptiert.\u00a0Dar\u00fcber hinaus hilft dieses Verfahren, die \u00dcberlebensf\u00e4higkeit zu verbessern und Brustschmerzen zu lindern. Koreanische Koronarstents kurbeln den Markt durch wachsende medizinische Infrastruktur an Der Markt f\u00fcr koronare Stents im asiatisch-pazifischen Raum ist im Prognosezeitraum eine der am schnellsten wachsenden Regionen mit einer hohen CAGR.\u00a0Korea ist eines der f\u00fchrenden L\u00e4nder, das das Wachstum des Marktes f\u00fcr koronare Stents durch den Ausbau der medizinischen Infrastruktur in der vorgesehenen Zeit erh\u00f6ht.\u00a0Die Hersteller in Korea haben in den letzten Jahren teure Medizinprodukte entwickelt und gem\u00e4\u00df den Anforderungen der Endbenutzer innovativ gearbeitet, um eine maximale Leistung zu erzielen.\u00a0Dar\u00fcber hinaus bringen diese Akteure hochwertige medizinische Verbrauchsmaterialien f\u00fcr die wirksame Behandlung von Patienten mit koronarer Herzkrankheit auf den Markt, was den koreanischen Markt f\u00fcr koronare Stents wahrscheinlich vergr\u00f6\u00dfern wird.\u00a0Die Hersteller von Koronarstents in Indien\u00a0haben sich weiterentwickelt, indem sie Innovation und Kosteneffizienz in den Vordergrund stellen, um in einer wettbewerbsintensiven Branche erfolgreich zu sein. Japanischer Markt f\u00fcr Koronarstents w\u00e4chst durch steigendes Bewusstsein f\u00fcr koronare Behandlungen Japan ist ein weiteres Land im asiatisch-pazifischen Raum, das im Prognosezeitraum ebenfalls den gr\u00f6\u00dften Anteil in der Region einnimmt. Das steigende Bewusstsein f\u00fcr die Behandlung von Herzkranzgef\u00e4\u00dfen und der sinkende Preis f\u00fcr Koronarstents haben das Wachstum des japanischen Marktes f\u00fcr Koronarstents im Prognosezeitraum gesteigert. Dar\u00fcber hinaus lassen der zunehmend sitzende Lebensstil und die zunehmende Behandlung der Krankheit die Nachfrage nach Koronarstents in Japan im Prognosezeitraum ansteigen. Dar\u00fcber hinaus treiben das wachsende Zentrum f\u00fcr Herzkrankheiten und die zunehmende Implantation von Koronarstents das Wachstum des japanischen Marktes f\u00fcr Koronarstents in den letzten Jahren voran. Wie gro\u00df ist die Chance in den USA? Die zunehmende Verbreitung von koronaren Herzkrankheiten (CAD) d\u00fcrfte das Marktwachstum steigern Die zunehmende Verbreitung koronarer Herzkrankheiten treibt in den USA die Nachfrage nach interventioneller Kardiologiebehandlung an. Patienten, die an einer langfristigen KHK leiden, entscheiden sich als erste Behandlungsmethode f\u00fcr eine Angioplastie. Dem National Center for Health Statistics zufolge ist in den USA jedes Jahr jeder vierte Todesfall auf eine koronare Herzkrankheit (KHK) zur\u00fcckzuf\u00fchren, etwa 785.000 Menschen erleiden in den USA ihren ersten Herzinfarkt und 470.000 einen Herzinfarkt. Dies ist auf ver\u00e4nderte Lebensgewohnheiten, Rauchen, Umweltverschmutzung und andere Faktoren zur\u00fcckzuf\u00fchren. Diese zunehmende Verbreitung von Erkrankungen der Herzkranzgef\u00e4\u00dfe und die h\u00f6heren Gesundheitsausgaben in L\u00e4ndern mit niedrigem bis mittlerem Einkommen werden voraussichtlich das Wachstum des globalen Marktes f\u00fcr Koronarstents im Prognosezeitraum ankurbeln. Wie lukrativ sind die M\u00f6glichkeiten in China? G\u00fcnstige staatliche Unterst\u00fctzung f\u00fcr die Entwicklung des Gesundheitswesens wird den Markt positiv antreiben Erh\u00f6hte staatliche Investitionen in das Gesundheitswesen und die Durchf\u00fchrung neuer Initiativen zur Einf\u00fchrung erschwinglicher Ger\u00e4te in M\u00e4rkten mit Kostenbeschr\u00e4nkungen wie China beeinflussen diesen Markt ebenfalls. Um beispielsweise \u00fcberh\u00f6hte Preise und andere Probleme bei der Lieferung teurer medizinischer Hilfsmittel anzugehen, hat die chinesische Regierung im Januar 2021 ein zentrales Beschaffungsprogramm f\u00fcr hochwertige medizinische Verbrauchsmaterialien eingef\u00fchrt. Mit dieser Initiative will die Regierung die Zulieferer \u00fcberspringen und die Artikel direkt beim Hersteller kaufen, um die \u00fcberh\u00f6hten Preise zu senken. Infolgedessen sind die Kosten f\u00fcr Koronarstents in China drastisch gesunken. Der Durchschnittspreis f\u00fcr Koronarstents wurde seit 2019 um 93 % gesenkt, um die nationale Ausschreibung zu gewinnen. Marktchancen f\u00fcr Koronarstents \u2013 t\u00e4glich Der Markt f\u00fcr Koronarstents bietet t\u00e4glich bedeutende Chancen, insbesondere in Schwellenm\u00e4rkten, in denen sich die Gesundheitsinfrastruktur verbessert. Die zunehmende Verf\u00fcgbarkeit erschwinglicher Gesundheitsversorgung und das gestiegene Bewusstsein der Patienten f\u00fcr minimalinvasive Herzoperationen erm\u00f6glichen eine st\u00e4rkere Marktdurchdringung. Dar\u00fcber hinaus er\u00f6ffnen technologische Innovationen wie medikamentenfreisetzende Stents (DES) mit verbesserter Biokompatibilit\u00e4t und bioresorbierbare Stents der n\u00e4chsten Generation den Herstellern neue M\u00f6glichkeiten, sich von der Konkurrenz abzuheben und gr\u00f6\u00dfere Marktanteile zu erobern. Der Markt bietet auch die M\u00f6glichkeit f\u00fcr Partnerschaften zwischen Krankenh\u00e4usern und Stentherstellern, um die Lieferkette zu optimieren und die Verfahrenskosten zu senken. Dar\u00fcber hinaus wird sich mit der zunehmenden Verbreitung von Telemedizin und Ferngesundheitsdiensten der Zugang zu Herzbehandlungen und Stentverfahren in abgelegenen Regionen voraussichtlich dramatisch verbessern. Einblicke in Komponenten Der Markt ist nach Produkttypen segmentiert, wobei medikamentenfreisetzende Stents (DES) im Jahr 2025 aufgrund ihrer Wirksamkeit bei der Verhinderung von Restenosen den gr\u00f6\u00dften Marktanteil haben werden. Bare-Metal-Stents (BMS) und bioresorbierbare Gef\u00e4\u00dfst\u00fctzen (BVS) sind weitere Schl\u00fcsselkomponenten, wobei BVS im Prognosezeitraum voraussichtlich das schnellste Wachstum aufweisen werden. Zu den wichtigsten Materialsegmenten geh\u00f6ren metallische Stents (Kobalt-Chrom und Platin-Chrom) und Polymerstents , wobei letztere aufgrund ihrer biologisch abbaubaren Eigenschaften an Bedeutung gewinnen. Wettbewerbsumfeld Der Markt f\u00fcr Koronarstents hat im Laufe der Jahre bedeutende Fortschritte erzielt, die durch innovative Produktentwicklungen, neue Marktteilnehmer und sich entwickelnde regulatorische Standards vorangetrieben wurden. Diese Faktoren haben gemeinsam die Branche neu gestaltet und die Behandlungsm\u00f6glichkeiten f\u00fcr Patienten mit koronarer Herzkrankheit erweitert. Elunir-Perl, medikamentenfreisetzender Stent von Medinol. Der im Oktober 2023 von der FDA zugelassene Elunir-Perl stellt eine innovative L\u00f6sung f\u00fcr die Behandlung koronarer Herzkrankheiten dar. Dieser Stent wurde f\u00fcr eine sichere und wirksame Behandlung entwickelt und verf\u00fcgt \u00fcber fortschrittliche Technologie, um den Patientenbed\u00fcrfnissen in einer Vielzahl klinischer Szenarien gerecht zu werden. Xience Sierra von Abbott Laboratories Der 2018 mit FDA-Zulassung eingef\u00fchrte medikamentenfreisetzende Stent Xience Sierra wird f\u00fcr seine verbesserte Flexibilit\u00e4t und sein schlankes Profil gesch\u00e4tzt. Er ist in kleinen Durchmessern und gr\u00f6\u00dferen L\u00e4ngen erh\u00e4ltlich und wurde speziell f\u00fcr die Durchf\u00fchrung komplexer perkutaner Koronarinterventionen (PCI) entwickelt, wodurch die Patientenergebnisse in schwierigen F\u00e4llen verbessert werden. Resolute Onyx 2.0mm von Medtronic Der 2018 von der FDA zugelassene medikamentenfreisetzende Stent Resolute Onyx 2.0mm ist auf Patienten mit kleinen Koronararterien zugeschnitten. Sein auf Pr\u00e4zision ausgerichtetes Design bew\u00e4ltigt die Herausforderungen, die komplizierte anatomische Strukturen mit sich bringen, und gew\u00e4hrleistet eine wirksamere Behandlung f\u00fcr Patienten mit besonderen kardiovaskul\u00e4ren Anforderungen. Diese Fortschritte unterstreichen das Engagement der Branche f\u00fcr Innovation und patientenorientierte L\u00f6sungen und schaffen die Voraussetzungen f\u00fcr weitere Fortschritte in der Koronarstent-Technologie. Wichtige Marktteilnehmer TERUMO CORPORATION Boston Scientific ist eine gemeinn\u00fctzige Organisation, die sich auf die F\u00f6rderung von Wissenschaft und Technologie spezialisiert hat. Sie ist die erste in den USA und hat 19 Medtronic Gef\u00e4\u00dfkonzepte B. Braun Melsungen AG BIOTRONIK SE & Co. KG Abbott Laboratories Biosensors International Group, Ltd. HEXACATH STENTYS SA Segmentierung Nach Produkt: Medikamentfreisetzende Stents (DES), Bare-Metal-Stents (BMS), bioabsorbierbare Stents, selbstexpandierende Stents, ballonexpandierbare Stents usw. Nach Endbenutzer: Krankenh\u00e4user, Herzzentren, ambulante chirurgische Zentren und andere Gesundheitseinrichtungen. Nach Rohmaterial: Kobalt-Chrom, Edelstahl, Platin-Chrom, Nickel-Titan, Polymer Nach Region: Nordamerika, Lateinamerika, Westeuropa, S\u00fcdasien und Pazifik, Ostasien, Naher Osten und Afrika. Authored By Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher. Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation. Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News. Explore FMI's Extensive Coverage in the Healthcare Domain: During the projected timeframe, the non-vascular stents market is predicted to increase at a CAGR of 4.5%. (2022 - 2032). The aortic stents grafts market size is anticipated to be worth USD 2.5 billion in 2023. The market is assumed to surge at a CAGR of 5% during the forecast period and, reach USD 4.2 billion by 2033. The coronary artery bypass graft market is estimated to be valued at USD 17,612.1 million in 2023. The coronary artery bypass graft industry is likely to cross a valuation of USD 22,765.9 million by 2033. In 2023, the adoption of coronary stent in India stands at a valuation of USD 843.8 million. This surge is attributed to the demand for minimally invasive procedures to address the rising cases of cardiovascular diseases. The coronary intravascular lithotripsy market size is projected to be worth USD 324.4 Million in 2023. The market is likely to surpass USD 592.2 Million by 2033 at a CAGR of 6.2% during the forecast period The visual electrophysiology market is anticipated to flourish at a steady CAGR of 7.0% between 2023 and 2033. The immunochemistry analyzer market is expected to register a\u00a0CAGR of 16%\u00a0during the forecast period, up from\u00a0USD 14.2 Billion\u00a0in 2021, to reach a valuation of\u00a0USD 72.69 Billion\u00a0by 2032. The immunochemistry products market is anticipated to record a CAGR of 7.25% during the forecast period, up from USD 2.08 Billion in 2021 to reach a valuation of USD 4.5 Billion by 2032. The global birch allergy treatment market garnered a market value of\u00a0USD 571 Million\u00a0in 2023\u00a0and is expected to accumulate a market value of\u00a0USD 1123.24 Million\u00a0by registering a CAGR of\u00a07% The global nasal allergy treatment market enjoys a valuation of USD 6.6 Billion in 2022, and it is further projected to expand at a CAGR of 6.7% About Future Market Insights (FMI) Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in\u00a0Dubai\u00a0and has delivery centres in the\u00a0United Kingdom,\u00a0the United States, and\u00a0India. FMI's latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise. Contact Us Future Market Insights Inc. Christiana Corporate, 200 Continental Drive, Suite 401,\u00a0Newark, Delaware\u00a0- 19713,\u00a0USA T: +1-347-918-3531 For Sales Enquiries: sales@futuremarketinsights.com Website: https://www.futuremarketinsights.com LinkedIn | Twitter | Blogs | YouTube View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BVS", "date": "2025-01-09T15:30:00", "sentiment": {"score": 0.8934296220541, "confidence": 0.9030513167381287, "probabilities": {"positive": 0.9030513167381287, "negative": 0.009621694684028625, "neutral": 0.08732698112726212}}, "embedding": [-0.011223350651562214, 0.045134082436561584, 0.0062062498182058334, -0.03080182708799839, -0.007091485895216465, -0.0858985036611557, -0.15298210084438324, 0.19725394248962402, 0.0778007060289383, -0.06030035763978958, -0.04521189630031586, 0.07464560866355896, -0.010677598416805267, 0.11406736075878143, 0.09620034694671631, -0.18129101395606995, 0.04656080901622772, -0.03156960383057594, -0.070075124502182, 0.10379219800233841, 0.03135715797543526, 0.01924697495996952, -0.05599155277013779, -0.021441418677568436, -0.11487618088722229, -0.02391268126666546, -0.12730446457862854, -0.11287343502044678, -0.06183788925409317, 0.1034395694732666, 0.022766072303056717, 0.09336704015731812, -0.030613485723733902, -0.10227993130683899, -0.024964671581983566, -0.036565981805324554, -0.09902137517929077, 0.09958768635988235, -0.15274971723556519, 0.02909720689058304, 0.10460013151168823, -0.1750827133655548, -0.18942423164844513, -0.167708620429039, 0.1974414885044098, -0.16184581816196442, -0.08429332077503204, -0.032184213399887085, 0.00037119421176612377, 0.14872676134109497, -0.15885089337825775, -0.13143116235733032, -0.034377243369817734, 0.01071230135858059, -0.13592399656772614, -0.08754183351993561, -0.051392462104558945, -0.20096778869628906, -0.016154121607542038, -0.07605573534965515, -0.007604479324072599, -0.12964123487472534, 0.05817688629031181, 0.036358751356601715, -0.16724145412445068, -0.06539615243673325, 0.052564606070518494, -0.08324326574802399, 0.07726231217384338, 0.06704990565776825, 0.0660848468542099, -0.035640135407447815, -0.16630388796329498, 0.0961410403251648, 0.029523666948080063, 0.11281516402959824, 0.1264723390340805, -0.010345997288823128, 0.09125225991010666, -0.05617225170135498, 0.20619915425777435, 0.04140334203839302, 0.014524538069963455, -0.04612274840474129, 0.07171344757080078, 0.1306259036064148, -0.028255406767129898, 0.04461115598678589, -0.0707077607512474, -0.0825008898973465, 0.14999622106552124, 0.10717850923538208, 0.0008278172463178635, 0.20236951112747192, -0.01861564815044403, -0.035246774554252625, -0.03048480488359928, 0.022046387195587158, 0.004005098715424538, -0.019154658541083336, 0.154245063662529, -0.012238752096891403, -0.05171592906117439, 0.08266296982765198, -0.09873399883508682, -0.11248420178890228, -0.026754429563879967, -0.011403743177652359, 0.026927823200821877, 0.013121278956532478, -0.03336728364229202, -0.0010724435560405254, 0.03949183598160744, -0.06254179775714874, -0.04670828580856323, 0.16912999749183655, -0.024872664362192154, 0.0048217992298305035, -0.01832715794444084, 0.15510234236717224, 0.025720639154314995, -0.011467678472399712, -0.020108487457036972, -0.040201880037784576, 0.05377306044101715, 0.08423388004302979, -0.061004262417554855, 8.514274560318759e-33, -0.02885156311094761, -0.006194441579282284, 0.08848537504673004, -0.005965083837509155, -0.09095294028520584, 0.010036619380116463, 0.04776608943939209, 0.02825256623327732, 0.03142906352877617, -0.17362284660339355, -0.1841651052236557, 0.033427659422159195, -0.07230497151613235, 0.2272583395242691, -0.03808782994747162, -0.03174714371562004, 0.13601359724998474, 0.14547279477119446, 0.05405294895172119, -0.03047967329621315, 0.03516755625605583, -0.11020176112651825, 0.03433871641755104, 0.010351978242397308, -0.01057305745780468, -0.0008109565824270248, -0.009540271013975143, -0.04719078913331032, -0.07417672127485275, 0.03433427959680557, -0.1564520001411438, -0.07928131520748138, 0.1918087899684906, -0.14743494987487793, -0.04274902120232582, -0.051306918263435364, -0.0511309988796711, -0.12185374647378922, 0.0046634492464363575, 0.06318552792072296, -0.015332212671637535, 0.18931493163108826, -0.0687033161520958, 0.03617885708808899, 0.12565384805202484, 0.07371237128973007, 0.008355721831321716, 0.08347246795892715, -0.04332614690065384, -0.045796338468790054, -0.118069127202034, 0.14549747109413147, -0.09293413162231445, 0.017141718417406082, -0.022530313581228256, 0.04468949884176254, -0.026681987568736076, -0.08475907891988754, -0.007129661738872528, 0.025488104671239853, -0.1952352076768875, 0.14057791233062744, -0.013582626357674599, 0.17016825079917908, -0.21308375895023346, 0.12236841022968292, 0.08577782660722733, 0.01240449771285057, -0.1351640522480011, 0.11091086268424988, 0.013661318458616734, 0.09745005518198013, -0.00018217414617538452, -0.06968417763710022, 0.13600002229213715, 0.056974902749061584, 0.11866913735866547, 0.17521432042121887, 0.04278675466775894, -0.13462872803211212, -0.13861677050590515, 0.09281705319881439, -0.15867355465888977, -0.011351944878697395, 0.05149253457784653, 0.03601990267634392, 0.0811147391796112, 0.024109281599521637, 0.03552022576332092, -0.09533048421144485, -0.041142888367176056, 0.05752912163734436, -0.06547050178050995, 0.09751914441585541, 0.023918569087982178, -9.885302110824764e-33, -0.06524530053138733, -0.006757889874279499, -0.000965791754424572, -0.04281267151236534, 0.10566915571689606, 0.058884818106889725, -0.03535965457558632, -0.12254302203655243, 0.16556140780448914, -0.179130420088768, -0.08882561326026917, 0.06443028151988983, 0.09443964064121246, -0.022493425756692886, -0.025407657027244568, 0.10267393290996552, -0.06229899451136589, -0.15694484114646912, -0.139586940407753, 0.04433615878224373, 0.05820056423544884, 0.11553637683391571, -0.018249977380037308, 0.1414981633424759, -0.04695364832878113, 0.03751911595463753, -0.09854647517204285, -0.08929460495710373, 0.19940787553787231, -0.0449795201420784, -0.018633022904396057, -0.05426087975502014, -0.18560005724430084, 0.05764800310134888, -0.03170709311962128, 0.07009115070104599, 0.09632871299982071, 0.02782696671783924, 0.046472907066345215, -0.0017782594077289104, -0.00912470556795597, -0.013008051551878452, -0.08070778101682663, -0.10834021866321564, -0.08951099216938019, -0.06428854912519455, 0.17771786451339722, -0.11594957113265991, 0.19545038044452667, -0.003138198284432292, -0.020670216530561447, -0.005059787072241306, -0.007769516669213772, 0.1495673954486847, -0.159976527094841, -0.022719858214259148, 0.06914548575878143, 0.07386349141597748, -0.11283418536186218, 0.02589588053524494, 0.047129545360803604, 0.1640830636024475, 0.05799783766269684, -0.15261310338974, 0.11047471314668655, 0.027988716959953308, 0.22639840841293335, -0.029154963791370392, -0.041009239852428436, -0.12795166671276093, 0.03637394681572914, 0.0038477377966046333, 0.012817725539207458, -0.02226448431611061, -0.019275322556495667, 0.0027512023225426674, 0.0429421104490757, -0.11059701442718506, -0.16623646020889282, 0.06531190872192383, -0.006428608670830727, -0.014227076433598995, -0.005359739065170288, -0.11287032812833786, 0.018800418823957443, 0.011933835223317146, -0.004873927216976881, -0.04681318253278732, -0.11678527295589447, 0.14049944281578064, -0.13310392200946808, 0.02858804166316986, -0.13012778759002686, -0.006090166047215462, -0.07034578174352646, -1.0010165851781494e-07, -0.014016238041222095, -0.014875397086143494, -0.08060532808303833, -0.02024681493639946, -0.19724957644939423, -0.15255291759967804, -0.0002916622906923294, 0.07154625654220581, 0.042466409504413605, 0.0441809706389904, 0.1835494339466095, 0.1855231374502182, 0.07428853958845139, -0.07614916563034058, -0.08429460972547531, 0.060976795852184296, -0.21243348717689514, -0.010656913742423058, -0.026409145444631577, -0.11838173866271973, -0.050375550985336304, -0.012483570724725723, 0.05650309473276138, -0.08677801489830017, -0.004826721735298634, -0.05437013506889343, 0.09512445330619812, 0.039018403738737106, 0.05437152087688446, 0.0037952670827507973, -0.03389245644211769, -0.10817855596542358, 0.19566354155540466, 0.21092991530895233, 0.2571712136268616, -0.0619688518345356, 0.08169835060834885, -0.020480304956436157, -0.04533679038286209, 0.27197930216789246, 0.024839524179697037, -0.08026326447725296, -0.03667882829904556, 0.004743609577417374, -0.04141509532928467, -0.1833679974079132, -0.05670967325568199, 0.05229096859693527, 0.00456297816708684, 0.08223342895507812, -0.08541418612003326, -0.04740363359451294, 0.009858978912234306, 0.006132729351520538, -0.011379319243133068, 0.13689196109771729, -0.07546438276767731, -0.04461975023150444, 0.027015065774321556, 0.10581205785274506, 0.08876407146453857, -0.26501214504241943, 0.26084816455841064, 0.13070768117904663], "changes": {"1wk": 4.633624111518238}}, {"text": "Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference Bioventus, Inc. Tue, Jan 7, 2025, 4:00 PM 1 min read In This Article: BVS Bioventus, Inc. DURHAM, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, chief executive officer, will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 10:30 a.m. PT (1:30 p.m. ET). The live webcast of the presentation, including Q&A, may be accessed on the Investors section of the Bioventus website and will be available until February 15, 2025. About Bioventus Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com , and follow the Company on LinkedIn and Twitter . Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC. Investor and Media Inquiries: Dave Crawford 919-474-6787 dave.crawford@bioventus.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BVS", "date": "2025-01-07T16:00:00", "sentiment": {"score": 0.09164741914719343, "confidence": 0.10110832750797272, "probabilities": {"positive": 0.10110832750797272, "negative": 0.009460908360779285, "neutral": 0.8894307017326355}}, "embedding": [-0.1485619843006134, -0.03288016840815544, 0.10599404573440552, 0.014080796390771866, -0.037288542836904526, 0.045202597975730896, -0.03690136969089508, 0.09523308277130127, 0.048241157084703445, -0.020329074934124947, -0.08390679955482483, 0.08326449990272522, -0.036415908485651016, 0.1423717439174652, -0.013244029134511948, -0.04294344782829285, 0.09191340208053589, 0.00024894895614124835, -0.08103188127279282, 0.007500114850699902, 0.005290512461215258, 0.0634140744805336, 0.1654159277677536, 0.05066962167620659, -0.16733267903327942, 0.00582565413787961, -0.03242553025484085, -0.059734415262937546, -0.05153268203139305, -0.0680106058716774, 0.05670761689543724, -0.026594404131174088, 0.025338582694530487, -0.2112346589565277, 0.06301428377628326, 0.026592416688799858, -0.11270872503519058, 0.025528907775878906, -0.060170236974954605, -0.030912665650248528, 0.0729266032576561, -0.12467936426401138, -0.11726934462785721, 0.038549575954675674, 0.11595220118761063, -0.05421644449234009, 0.02337201125919819, -0.014670894481241703, 0.0543360561132431, 0.03876476362347603, -0.16834451258182526, -0.16398727893829346, 0.07670154422521591, -0.08683756738901138, -0.023990390822291374, -0.019590459764003754, -0.06553387641906738, -0.07372746616601944, -0.013690439984202385, -0.12699973583221436, 0.06819325685501099, -0.06377120316028595, 0.06153697520494461, 0.12890179455280304, -0.03265804424881935, 0.08943444490432739, 0.04995061084628105, 0.02647419646382332, -0.04184591770172119, 0.010056139901280403, -0.010491404682397842, -0.024532034993171692, 0.09044532477855682, 0.11683937162160873, -0.03266220912337303, 0.08981918543577194, 0.12360262870788574, 0.02732008323073387, 0.04144421964883804, -0.013037950731813908, 0.08408211916685104, -0.0044051907025277615, 0.035828787833452225, 0.08070061355829239, -0.033081259578466415, 0.06015460193157196, 0.04556291550397873, -0.008006973192095757, -0.07923854887485504, 0.018577927723526955, -0.0005188520881347358, 0.01894875429570675, 0.06268248707056046, -0.05474073067307472, 0.011375265195965767, 0.01804962567985058, -0.13548129796981812, 0.021525587886571884, -0.06310929358005524, -0.06730419397354126, -0.04012277349829674, 0.06198734790086746, -0.07508785277605057, -0.07346519827842712, 0.05323057249188423, 0.007952607236802578, -0.15036922693252563, -0.08329787105321884, 0.2241259515285492, 0.09244082123041153, -0.06562690436840057, 0.12058717012405396, -0.06611491739749908, -0.01777886226773262, -0.04061146453022957, 0.12511400878429413, -0.026567021384835243, 0.10346561670303345, 0.18918494880199432, -0.0422799326479435, 0.14163483679294586, -0.06822968274354935, 0.03679386153817177, -0.12181486934423447, 0.007158785592764616, 0.01788231171667576, -0.06068070977926254, 6.0319901191850426e-33, -0.00163660803809762, 0.0035854463931173086, 0.0938841849565506, 0.032066620886325836, 0.043012164533138275, 0.020594492554664612, -0.03289300575852394, -0.07612650096416473, -0.07025186717510223, -0.03163258358836174, -0.21232764422893524, 0.030859537422657013, 0.09819955378770828, 0.14104081690311432, -0.14381012320518494, -0.09105774760246277, -0.20084702968597412, 0.01644122786819935, -0.05565876513719559, -0.10579993575811386, 0.054838959127664566, -0.024622086435556412, 0.042967986315488815, 0.13766664266586304, -0.0018933175597339869, 0.006888857576996088, 0.017608756199479103, 0.11373349279165268, 0.15741537511348724, 0.04639182239770889, -0.14685514569282532, 0.010319147258996964, -0.0073747774586081505, -0.14846257865428925, -0.12295933067798615, -0.024535274133086205, -0.08780902624130249, -0.23491357266902924, -0.008325359784066677, -0.05492487922310829, 0.0119463000446558, 0.05432333052158356, -0.08502289652824402, -0.05212102457880974, 0.06980504840612411, -0.08005176484584808, -0.06882792711257935, 0.030303960666060448, 0.13278785347938538, -0.08845622092485428, -0.06821326911449432, 0.07056174427270889, 0.11258336156606674, -0.1700471043586731, -0.014236526563763618, -0.08635000139474869, -0.033372245728969574, -0.00410038884729147, 0.03819560632109642, 0.12984725832939148, 0.058303747326135635, 0.13442379236221313, 0.031061306595802307, 0.07817310094833374, -0.17268121242523193, 0.16967739164829254, -0.014743711799383163, 0.00381093448959291, -0.13547025620937347, 0.07685600221157074, 0.10528110712766647, 0.07668411731719971, -0.026136409491300583, -0.061339374631643295, -0.018607033416628838, -0.03691704571247101, 0.0004251576028764248, 0.007356232963502407, -0.109989233314991, -0.0006367614259943366, -0.06940391659736633, -0.01858573965728283, -0.03461936488747597, 0.1989784687757492, 0.14150075614452362, -0.038236044347286224, -0.0800788626074791, 0.022590400651097298, -0.050557348877191544, -0.0517515167593956, 0.05261189490556717, -0.0365356020629406, -0.03287352994084358, 0.20967070758342743, -0.09928339719772339, -7.988424509318101e-33, -0.08304388076066971, 0.05152909457683563, 0.09434102475643158, 0.018874937668442726, 0.07132688164710999, -0.0486166812479496, 0.002901305677369237, -0.013786411844193935, 0.05494624376296997, -0.06710147112607956, -0.03955793008208275, 0.08737145364284515, -0.0900353193283081, -0.004496438428759575, -0.05154908075928688, 0.06593364477157593, -0.012308701872825623, -0.08714739978313446, -0.11268078535795212, 0.0223931223154068, 0.03200403228402138, 0.20060740411281586, -0.04155663028359413, 0.03366956114768982, 0.04110369458794594, 0.05953478813171387, 0.11448443681001663, 0.03687693551182747, 0.10295169800519943, -0.04803398624062538, -0.032635677605867386, 0.032805368304252625, -0.24490603804588318, -0.005667129531502724, 0.006728912703692913, 0.12029922753572464, 0.0760529562830925, -0.1899368017911911, 0.05016854777932167, -0.10079386830329895, 0.11780092120170593, -0.022837383672595024, -0.1120731309056282, 0.12056863307952881, 0.05823803320527077, 0.03922806307673454, -0.10225726664066315, -0.07454188168048859, 0.03688894957304001, 0.15532812476158142, -0.04436545446515083, 0.01766270212829113, 0.023744218051433563, 0.04101687669754028, 0.022689489647746086, -0.018825680017471313, 0.025637226179242134, 0.03184108808636665, -0.07691646367311478, 0.04890892654657364, -0.006261911243200302, 0.05293926224112511, 0.07652553170919418, 0.06092211604118347, 0.04014071822166443, 0.1080130860209465, 0.12999315559864044, 0.12270410358905792, -0.13679549098014832, -0.06854017078876495, 0.023190002888441086, 0.0158230010420084, -0.20048418641090393, -0.09296295791864395, -0.03931794688105583, 0.15939801931381226, -0.05388043448328972, -0.17041683197021484, -0.1424405425786972, 0.033580075949430466, 0.06666824966669083, -0.06210119277238846, 0.07177412509918213, 0.017858166247606277, 0.02491893246769905, -0.011357150040566921, -0.022945793345570564, 0.05774756893515587, -0.03277038782835007, 0.14209572970867157, -0.03145653009414673, -0.07916363328695297, -0.08939944207668304, 0.17722012102603912, 0.0646921917796135, -1.0012892204258605e-07, 0.09035419672727585, -0.007991950958967209, 0.09934531897306442, -0.09541431814432144, -0.013024315237998962, -0.11407995223999023, -0.06344935297966003, -0.0226622074842453, -0.021383559331297874, 0.049634527415037155, 0.004528083838522434, 0.10163599997758865, -0.03229186683893204, 0.12017549574375153, 0.028888873755931854, 0.041273102164268494, -0.16037166118621826, 0.106892429292202, -0.08911480009555817, -0.08978897333145142, -0.07228340953588486, 0.015268413349986076, 0.0551924891769886, -0.08837500959634781, 0.12209893018007278, -0.10297165811061859, -0.0505179725587368, 0.022008879110217094, 0.0004321190353948623, -0.09170586615800858, 0.006821922957897186, -0.046801306307315826, 0.09396916627883911, 0.04871893674135208, -0.021917423233389854, -0.11200300604104996, -0.07269308716058731, 0.023138126358389854, 0.02589535340666771, 0.04581017792224884, -0.07682892680168152, -0.08389682322740555, -0.02904384210705757, 0.050412341952323914, -0.0680014118552208, -0.048517659306526184, -0.14798836410045624, 0.021514881402254105, -0.02375965006649494, 0.05946199968457222, 0.017063135281205177, -0.07418786734342575, 0.06148242577910423, -0.04201461374759674, -0.09420083463191986, 0.1477634459733963, -0.019776852801442146, -0.018760714679956436, 0.10340777039527893, -0.024111296981573105, 0.11928020417690277, -0.11187327653169632, 0.1279258131980896, 0.031779881566762924], "changes": {"1wk": -4.0837731469484275}}, {"text": "3 Promising ASX Penny Stocks With At Least A$40M Market Cap editorial-team@simplywallst.com (Simply Wall St) Wed, Jan 8, 2025, 4:06 AM 4 min read In This Article: MEU.AX BVSFF ESR.AX ESROB.AX The Australian stock market is experiencing a cautious start to the day, with shares expected to open nearly flat amid global economic uncertainties and recent sell-offs in the U.S. technology sector. Despite these challenges, opportunities remain for investors willing to explore lesser-known areas of the market. Penny stocks, though often considered niche investments, can offer unique growth potential when supported by strong financial health and solid fundamentals. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Embark Early Education (ASX:EVO) A$0.775 A$142.2M \u2605\u2605\u2605\u2605\u2606\u2606 LaserBond (ASX:LBL) A$0.565 A$66.23M \u2605\u2605\u2605\u2605\u2605\u2605 SHAPE Australia (ASX:SHA) A$2.86 A$237.13M \u2605\u2605\u2605\u2605\u2605\u2605 Austin Engineering (ASX:ANG) A$0.53 A$328.68M \u2605\u2605\u2605\u2605\u2605\u2606 Vita Life Sciences (ASX:VLS) A$1.90 A$106.54M \u2605\u2605\u2605\u2605\u2605\u2605 Helloworld Travel (ASX:HLO) A$2.04 A$332.15M \u2605\u2605\u2605\u2605\u2605\u2605 SKS Technologies Group (ASX:SKS) A$1.59 A$228.62M \u2605\u2605\u2605\u2605\u2605\u2605 Navigator Global Investments (ASX:NGI) A$1.625 A$796.38M \u2605\u2605\u2605\u2605\u2605\u2606 IVE Group (ASX:IGL) A$2.08 A$322.17M \u2605\u2605\u2605\u2605\u2606\u2606 Servcorp (ASX:SRV) A$4.99 A$492.34M \u2605\u2605\u2605\u2605\u2606\u2606 Click here to see the full list of 1,051 stocks from our ASX Penny Stocks screener. Let's review some notable picks from our screened stocks. Bravura Solutions Simply Wall St Financial Health Rating: \u2605\u2605\u2605\u2605\u2605\u2605 Overview: Bravura Solutions Limited develops, licenses, and maintains software applications for the wealth management and funds administration sectors across Australia, the United Kingdom, New Zealand, and internationally with a market cap of A$1.01 billion. Operations: Bravura Solutions generates revenue from two primary segments: Wealth Management, contributing A$163.13 million, and Funds Administration, with A$87.28 million. Market Cap: A$1.01B Bravura Solutions has recently raised its revenue guidance for fiscal 2025 to A$240 million to A$245 million, reflecting positive momentum. The company is debt-free, with short-term assets of A$154.8 million comfortably covering both short and long-term liabilities. Bravura has become profitable in the past year, although its Return on Equity remains low at 6.6%. Despite a relatively inexperienced board and management team, the company trades slightly below its estimated fair value and shows stable weekly volatility at 8%, indicating potential stability amidst growth prospects in the software sector. Get an in-depth perspective on Bravura Solutions' performance by reading our balance sheet health report here. Gain insights into Bravura Solutions' future direction by reviewing our growth report. ASX:BVS Debt to Equity History and Analysis as at Jan 2025 Estrella Resources Simply Wall St Financial Health Rating: \u2605\u2605\u2605\u2605\u2605\u2605 Overview: Estrella Resources Limited, with a market cap of A$45.62 million, is involved in the exploration of mineral resources in Western Australia and Timor-Leste. Story Continues Operations: Estrella Resources Limited has not reported any specific revenue segments. Market Cap: A$45.62M Estrella Resources Limited, with a market cap of A$45.62 million, is pre-revenue and currently unprofitable. The company recently completed a follow-on equity offering of A$1.25 million, which may extend its cash runway beyond the current two months based on free cash flow estimates. Despite having no debt and short-term assets exceeding liabilities, Estrella's share price has been highly volatile over the past three months. Shareholders have experienced dilution with an 8.1% increase in shares outstanding over the past year, while management's average tenure suggests some level of experience within the team. Take a closer look at Estrella Resources' potential here in our financial health report. Learn about Estrella Resources' historical performance here. ASX:ESR Debt to Equity History and Analysis as at Jan 2025 Marmota Simply Wall St Financial Health Rating: \u2605\u2605\u2605\u2605\u2605\u2605 Overview: Marmota Limited is an Australian company focused on the exploration of mineral properties, with a market capitalization of A$48.90 million. Operations: Marmota Limited does not report any specific revenue segments. Market Cap: A$48.9M Marmota Limited, with a market capitalization of A$48.90 million, is pre-revenue and remains unprofitable. Its short-term assets of A$3.7 million comfortably cover both short-term and long-term liabilities, indicating sound liquidity management despite shareholder dilution over the past year. The company benefits from an experienced board and management team, with average tenures of 3.7 years and 5.3 years respectively, suggesting stability in leadership. Marmota's cash runway extends beyond one year based on current free cash flow levels, providing some financial flexibility as it continues its exploration activities without any debt burden. Jump into the full analysis health report here for a deeper understanding of Marmota. Review our historical performance report to gain insights into Marmota's track record. ASX:MEU Debt to Equity History and Analysis as at Jan 2025 Turning Ideas Into Actions Explore the 1,051 names from our ASX Penny Stocks screener here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Interested In Other Possibilities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value . This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:BVS ASX:ESR and ASX:MEU. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BVS", "date": "2025-01-08T04:06:11", "sentiment": {"score": 0.014474723488092422, "confidence": 0.056825052946805954, "probabilities": {"positive": 0.056825052946805954, "negative": 0.04235032945871353, "neutral": 0.9008246660232544}}, "embedding": [0.016544535756111145, -0.12408943474292755, -0.11776335537433624, 0.065109483897686, 0.006153380498290062, 0.02532818540930748, 0.02298305183649063, 0.04783501476049423, 0.000578342005610466, 0.01711433008313179, -0.07268325984477997, 0.02925744466483593, -0.023694142699241638, 0.02771727740764618, -0.03557087853550911, -0.08120641857385635, 0.08007453382015228, -0.08056771755218506, 0.05849242955446243, 0.08059963583946228, -0.034014225006103516, -0.044138386845588684, -0.04444902762770653, 0.026812909170985222, 0.07347872108221054, 0.03526033088564873, -0.001117214560508728, 0.028725819662213326, -0.21891167759895325, -0.2640290856361389, -0.050488412380218506, 0.06406572461128235, 0.1018124520778656, -0.15426474809646606, 0.015229431912302971, -0.0128706693649292, 0.044396787881851196, 0.041681792587041855, -0.05286688730120659, -0.09520379453897476, 0.038051359355449677, -0.023470904678106308, -0.008044853806495667, 0.05380510538816452, 0.03653697669506073, -0.2261989861726761, 0.008923867717385292, -0.04804568365216255, 0.16394969820976257, 0.05288495868444443, -0.03019208088517189, 0.012170885689556599, 0.0603574700653553, -0.046227287501096725, -0.2007448822259903, 0.034754250198602676, -0.15514840185642242, 0.005384803283959627, 0.03688162565231323, -0.15277495980262756, 0.09421608597040176, -0.046981196850538254, 0.013198346830904484, 0.03630124405026436, 0.11762623488903046, 0.07752455025911331, -0.1899809092283249, 0.04302774742245674, -0.04410038888454437, -0.08392344415187836, -0.007519644685089588, -0.10497263073921204, -0.11754535138607025, 0.03099830076098442, -0.04266625642776489, 0.13510683178901672, 0.16795799136161804, -0.06122828274965286, 0.05758536234498024, 0.0038429126143455505, -0.07605341076850891, -0.03240525349974632, 0.04670071229338646, 0.0028327079489827156, -0.039507266134023666, 0.03343991935253143, 0.14172938466072083, 0.015266817063093185, 0.08581698685884476, -0.14866185188293457, 0.03965524584054947, 0.06339677423238754, -0.029142465442419052, -0.002612706273794174, 0.11447124183177948, -0.0840398520231247, 0.021799743175506592, -0.04217485710978508, -0.06872625648975372, 0.05330242961645126, 0.18717199563980103, -0.0877385139465332, -0.07217032462358475, 0.08380968868732452, -0.03619321435689926, -0.09000612795352936, 0.013136514462530613, -0.08788198977708817, 0.1439678966999054, -0.038649782538414, -0.020347915589809418, 0.0749892070889473, -0.11757209151983261, -0.08906233310699463, -0.103256955742836, 0.03599994257092476, -0.038585007190704346, -0.06847687065601349, 0.21372953057289124, 0.026303762570023537, 0.10030975937843323, 0.0023187920451164246, -0.0211699977517128, 0.006774997804313898, 0.03744399547576904, 0.047536611557006836, -0.07969005405902863, 1.2956476528283815e-32, -0.2350456565618515, 0.14085689187049866, -0.053839247673749924, -0.08087149262428284, 0.008361360058188438, -0.05499502271413803, 0.06634188443422318, -0.08054537326097488, -0.20371435582637787, -0.029502375051379204, -0.14775970578193665, 0.1263338327407837, -0.04700237140059471, 0.05787498876452446, 0.052765022963285446, -0.1691933423280716, 0.056684624403715134, 0.07541830837726593, -4.618172533810139e-05, -0.12987120449543, -0.046177253127098083, 0.13144725561141968, -0.04834342002868652, 0.0385018065571785, -0.026577115058898926, -0.05027392879128456, -0.026686131954193115, -0.1376962661743164, 0.06053239852190018, 0.05108881741762161, 0.017622103914618492, 0.10148677229881287, -0.016515148803591728, -0.08851662278175354, -0.032024092972278595, -0.0009922534227371216, -0.105690598487854, -0.048118382692337036, 0.04963182657957077, -0.07710970938205719, -0.11540515720844269, 0.13619768619537354, -0.039571188390254974, 0.008766362443566322, -0.012588389217853546, -0.026493661105632782, -0.09406529366970062, 0.05569680035114288, 0.14718368649482727, -0.08053618669509888, -0.23834168910980225, 0.010311363264918327, -0.10573949664831161, 0.07474715262651443, 0.030398812144994736, -0.01461034081876278, -0.01525704376399517, -0.018241267651319504, -0.011501443572342396, 0.11319808661937714, 0.11137303709983826, 0.034669145941734314, -0.09925425797700882, -0.0944816917181015, -0.09991525113582611, 0.18883591890335083, 0.1121601015329361, 0.031057249754667282, -0.04023493453860283, 0.16706439852714539, -0.0927772969007492, 0.0509042888879776, 0.24244140088558197, -0.018048545345664024, 0.1389203667640686, 0.03680986166000366, 0.019021037966012955, 0.07262670993804932, 0.018635809421539307, -0.09569767117500305, -0.0037715453654527664, -0.017898578196763992, -0.08994822204113007, 0.05100967362523079, -0.02238890901207924, 0.016721628606319427, 0.009919274598360062, 0.001311054453253746, -0.053034618496894836, -0.11792623996734619, 0.05154299736022949, -0.1125892698764801, 0.08724814653396606, -0.012127695605158806, -0.13687360286712646, -1.2175961503649263e-32, -0.07197927683591843, -0.07070937007665634, -0.02692723274230957, 0.15531542897224426, -0.0068544563837349415, 0.045666031539440155, 0.11094304919242859, -0.05161615461111069, -0.05408914014697075, -0.07056458294391632, -0.013898832723498344, 0.20414003729820251, -0.025035317987203598, 0.006599701941013336, 0.021220151335000992, 0.10450403392314911, 0.057714320719242096, -0.03878001123666763, 0.02733759395778179, -0.13376684486865997, -0.05952208489179611, 0.18050062656402588, -0.1357472836971283, 0.1343136578798294, 0.035971499979496, 0.09250935912132263, -0.05989447236061096, 0.06633257120847702, -0.004848767071962357, 0.04189549386501312, -0.13576507568359375, 0.14626523852348328, -0.11097283661365509, 0.04084867238998413, -0.14649811387062073, 0.06258653104305267, 0.05331014469265938, 0.05005546659231186, -0.095430888235569, 0.05645681172609329, 0.069805808365345, -0.023012572899460793, 0.07611943781375885, 0.003661835566163063, 0.07881228625774384, -0.059285327792167664, -0.015987344086170197, 0.03710102289915085, 0.07636138796806335, 0.17697250843048096, -0.006575188133865595, 0.014852539636194706, 0.12034226953983307, 0.09909969568252563, -0.07932169735431671, -0.023288948461413383, -0.056532517075538635, 0.07363484054803848, -0.16426293551921844, -0.0027551259845495224, -0.003585838247090578, 0.1860094964504242, 0.0992247685790062, 0.07128943502902985, 0.026974797248840332, -0.05306991562247276, -0.09448070824146271, 0.028719933703541756, -0.1646730899810791, -0.11270718276500702, -0.019576631486415863, 0.02789408154785633, 0.09028701484203339, -0.17581728100776672, -0.025721050798892975, 0.11361821740865707, 0.09410775452852249, -0.028528667986392975, 0.02776915207505226, 0.13964219391345978, -0.11061599850654602, 0.1210065484046936, 0.020323175936937332, 0.10910452157258987, 0.054332129657268524, 0.14543166756629944, -0.05208474397659302, 0.006681187078356743, 0.05675622820854187, 0.022845987230539322, -0.05635663866996765, -0.09376613795757294, 0.04947582259774208, -0.08948390185832977, -0.05286776274442673, -9.952035640026224e-08, 0.03066825121641159, -0.07562857866287231, -0.02329552173614502, -0.08033163845539093, 0.08866411447525024, 0.06717926263809204, 0.05819406360387802, 0.03776324912905693, 0.08347153663635254, 0.144393652677536, 0.09679625183343887, -0.018659772351384163, -0.1279255449771881, -0.06746765226125717, -0.14891503751277924, 0.019282950088381767, 0.010842960327863693, 0.1755967140197754, -0.04859847202897072, -0.11559037864208221, 0.021204952150583267, 0.15216603875160217, 0.09646013379096985, -0.08759619295597076, 0.04894115403294563, -0.03943902626633644, -0.07426050305366516, -0.020807676017284393, 0.12606829404830933, 0.08061879873275757, -0.01753336563706398, -0.02068755216896534, 0.197305828332901, -0.0557820163667202, 0.0638989731669426, 0.027014117687940598, 0.014453504234552383, 0.22301790118217468, -0.0016820579767227173, 0.10853791236877441, -0.00814719870686531, -0.14366379380226135, 0.014401426538825035, -0.04811042919754982, -0.020896699279546738, 0.051722679287195206, -0.1102752685546875, -0.09181580692529678, 0.10418827831745148, -0.24802473187446594, -0.03321143984794617, -0.030260296538472176, 0.010817970149219036, 0.026977036148309708, -0.012399516999721527, 0.1483127772808075, -0.13631755113601685, -0.04988952726125717, 0.015972517430782318, 0.06218830868601799, 0.09059010446071625, -0.3050283193588257, 0.016853369772434235, 0.19869285821914673], "changes": {"1wk": -7.411273943646409}}, {"text": "Bioventus completes divestiture of its Advanced Rehabilitation business TipRanks Fri, Jan 3, 2025, 4:05 PM 1 min read In This Article: BVS https://www.tipranks.com/news/the-fly/okyo-pharma-receives-1-4m-in-non-dilutive-financing Bioventus ( BVS ) announced that it has successfully completed the divestiture of its Advanced Rehabilitation business to Accelmed Partners, a private equity firm focused on acquiring and growing commercial-stage HealthTech companies. The transaction, announced on October 1, 2024, enables Bioventus to continue improving its focus and execution within the Company\u2019s core businesses, while also delivering approximately $20 million of net closing proceeds to enhance liquidity. Don't Miss Our New Year's Offers: Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Published first on TheFly \u2013 the ultimate source for real-time, market-moving breaking financial news. Try Now>> Read More on BVS: Bioventus upgraded to Neutral from Underweight at JPMorgan Bioventus price target raised to $15 from $12 at Canaccord Bioventus Reports Strong Revenue Growth in Q3 2024 Bioventus trading resumes Bioventus trading halted, volatility trading pause View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "BVS", "date": "2025-01-03T16:05:24", "sentiment": {"score": 0.9117076741531491, "confidence": 0.9239569306373596, "probabilities": {"positive": 0.9239569306373596, "negative": 0.012249256484210491, "neutral": 0.06379377096891403}}, "embedding": [-0.07828615605831146, -0.03911038488149643, 0.00733994971960783, 0.02010365016758442, 0.003963898401707411, 0.0020208365749567747, 0.011026780121028423, 0.14162014424800873, 0.009887254796922207, 0.004514248110353947, 0.029508346691727638, 0.08960666507482529, -0.11830709129571915, 0.0779615193605423, -0.05569593608379364, 0.03666171804070473, 0.16491515934467316, 0.010135607793927193, -0.1636923998594284, 0.057388484477996826, -0.04259268194437027, -0.06585216522216797, 0.13376444578170776, 0.023657580837607384, 0.0665498599410057, -0.01359648909419775, -0.03166460990905762, -0.017106713727116585, -0.024643225595355034, -0.1493501514196396, 0.009882924146950245, 0.012476830743253231, 0.06298331916332245, -0.1544383466243744, 0.0025501057971268892, -0.004657036159187555, -0.026263350620865822, -0.0026465917471796274, 0.05386243015527725, -0.020544085651636124, 0.06601447612047195, -0.030375957489013672, -0.20605996251106262, -0.003666243050247431, 0.08570758253335953, -0.10624556988477707, -0.045199766755104065, -0.03622986748814583, 0.1533563882112503, -0.042998503893613815, -0.1739419847726822, -0.1488533467054367, 0.08911144733428955, 0.05397108197212219, -0.08955681324005127, -0.022725313901901245, -0.05130540579557419, -0.10384422540664673, 0.02114671841263771, -0.07709132879972458, 0.0969240814447403, -0.033717673271894455, 0.13865147531032562, 0.08179391920566559, 0.010958452709019184, 0.002190924948081374, -0.08443411439657211, -0.03871617093682289, -0.03092564083635807, -0.04338086023926735, 0.07137763500213623, -0.15958479046821594, 0.026234835386276245, 0.037551868706941605, -0.05663473159074783, 0.16426560282707214, 0.09477439522743225, 0.11018861830234528, 0.1003558337688446, -0.08095093071460724, 0.046811897307634354, -0.09069846570491791, -0.039135731756687164, 0.015966758131980896, -0.0631742775440216, 0.010837542824447155, -0.015728022903203964, 0.08784384280443192, 0.06783925741910934, 0.11779247224330902, 0.03433976694941521, -0.0215098038315773, 0.10297729074954987, -0.08618658781051636, 0.0357217974960804, 0.011705154553055763, -0.16651636362075806, -0.06106438860297203, 0.008617058396339417, -0.09033524990081787, 0.07060061395168304, 0.15855221450328827, -0.03325188532471657, 0.003189643146470189, 0.021196871995925903, 0.0025200049858540297, -0.003379660425707698, -0.03886142000555992, 0.21477459371089935, 0.024785296991467476, -0.016299907118082047, 0.09565834701061249, -0.016406329348683357, 0.02804575301706791, -0.12593679130077362, 0.2043759524822235, -0.07489850372076035, -0.006555378437042236, 0.09751207381486893, -0.021478693932294846, 0.10857316851615906, 0.01664905436336994, -0.05377180129289627, -0.0758383497595787, -0.038259003311395645, 0.07669443637132645, -0.1966237723827362, 1.2290809505776508e-32, -0.011758808977901936, -0.01847860775887966, -0.0351300947368145, 0.0074518779292702675, -0.05933244526386261, -0.022054532542824745, -0.015837347134947777, -0.12897150218486786, -0.17912311851978302, 0.013520433567464352, -0.2703436017036438, 0.07497277110815048, 0.026442470028996468, 0.1102910041809082, -0.06649938970804214, -0.22690734267234802, -0.06958829611539841, 0.05744084343314171, 0.0680750235915184, -0.019732153043150902, 0.13840876519680023, -0.11051588505506516, -0.024384519085288048, -0.02135053277015686, 0.12009283155202866, 0.04304592311382294, -0.010563381016254425, 0.10954732447862625, 0.09775254130363464, 0.04137761518359184, -0.0910639539361, -0.03650073707103729, -0.11524469405412674, -0.10715145617723465, -0.13028332591056824, -0.09423243999481201, -0.07214704900979996, -0.19236357510089874, 0.013606979511678219, 0.00037818687269464135, -0.03338325768709183, 0.15272141993045807, -0.0931975319981575, -0.13849014043807983, -0.009050282649695873, 0.008323254063725471, -0.041769105941057205, 0.03371120244264603, 0.12302198261022568, -0.0016836682334542274, -0.11368915438652039, -0.014248644933104515, 0.057380761951208115, -0.13138307631015778, -0.0622476264834404, -0.0061896126717329025, -0.016806216910481453, -0.07484825700521469, 0.016077324748039246, 0.07214085012674332, 0.05347473919391632, 0.2297370582818985, -0.09585848450660706, 0.013914692215621471, -0.20854583382606506, 0.22808979451656342, -0.016321225091814995, 0.12530630826950073, -0.26502975821495056, 0.1818491816520691, 0.08677208423614502, -0.024631671607494354, -0.002989739878103137, -0.054695844650268555, 0.020052529871463776, -0.055006224662065506, -0.06321986019611359, -0.061956893652677536, 0.04879428818821907, 0.026344899088144302, 0.08325129002332687, 0.031228909268975258, 0.034706685692071915, 0.12272433936595917, 0.10284072905778885, 0.01648952066898346, -0.03958748281002045, 0.05187985301017761, -0.010336725041270256, 0.06800442934036255, -0.043253786861896515, -0.03945032134652138, -0.04477515071630478, 0.19517257809638977, -0.11593049764633179, -1.3343416942479864e-32, -0.07524796575307846, 0.03039957955479622, 0.007400020025670528, 0.020482569932937622, 0.03912622854113579, -0.037761058658361435, 0.03942088410258293, 0.06920775026082993, 0.05171987786889076, 0.00631228182464838, -0.03700444847345352, 0.10565441101789474, -0.061907146126031876, 0.03300231695175171, 0.046837855130434036, 0.02250560186803341, -0.0712856724858284, -0.0783623680472374, -0.02044793963432312, -0.050903212279081345, 0.0276735071092844, 0.1269897073507309, -0.08122146129608154, 0.20239868760108948, 0.07033035159111023, 0.13830767571926117, 0.08467549085617065, 0.12617318332195282, -0.0019105275860056281, -0.011627266183495522, -0.06211179867386818, 0.05420459806919098, -0.1909373551607132, 0.10524644702672958, 0.007603021804243326, 0.095759317278862, 0.045932214707136154, -0.1768239587545395, 0.010717728175222874, -0.09599502384662628, 0.09720093756914139, 0.052206944674253464, -0.09710464626550674, 0.10692182183265686, 0.07458647340536118, 0.019886024296283722, -0.08841517567634583, -0.04403835907578468, 0.15607014298439026, 0.048020727932453156, -0.02462083473801613, 0.05461663380265236, 0.07949455082416534, 0.15052784979343414, -0.029628681018948555, -0.025774730369448662, 0.13190729916095734, 0.05667318403720856, -0.12703247368335724, -0.06250682473182678, -0.0009144154610112309, -0.02510709874331951, 0.06763745099306107, 0.03717929869890213, -0.0474107451736927, 0.09408579766750336, 0.10635097324848175, 0.047269612550735474, -0.166927769780159, -0.15056835114955902, 0.08356354385614395, -0.03231954574584961, -0.04878010228276253, -0.14127516746520996, -0.07435166835784912, 0.3331911265850067, -0.03741442412137985, -0.1630145013332367, -0.05572081729769707, 0.010531471110880375, 0.046284060925245285, -0.07882736623287201, 0.08176126331090927, -0.06414533406496048, 0.033054981380701065, 0.08317966014146805, -0.09394866973161697, -0.015043964609503746, -0.08313530683517456, 0.07524193823337555, -0.11250003427267075, -0.21306633949279785, -0.004510446451604366, 0.11518385261297226, 0.032899126410484314, -1.0019141427619616e-07, 0.027953028678894043, -0.012540362775325775, 0.075179822742939, -0.030913420021533966, 0.10829173773527145, -0.11038485914468765, -0.05009358748793602, -0.013879146426916122, 0.08085740357637405, 0.04089359566569328, 0.027831517159938812, 0.04785933345556259, -0.09369301795959473, 0.16018903255462646, -0.005673260428011417, 0.012552888132631779, -0.20581050217151642, 0.08229101449251175, 0.009685046970844269, -0.030920127406716347, 0.032794754952192307, 0.027216382324695587, 0.008367015980184078, 0.0015890857903286815, 0.10289512574672699, -0.10747833549976349, -0.02030928246676922, 0.009864028543233871, 0.12358073890209198, -0.0011012951144948602, -0.007455273997038603, 0.014923358336091042, 0.03538869321346283, 0.06843084841966629, 0.003935409709811211, -0.08553390949964523, 0.007977182976901531, 0.06849995255470276, 0.0005474755307659507, 0.08819623291492462, -0.08922190219163895, -0.13286103308200836, -0.06368523091077805, -0.0325053445994854, -0.00861090887337923, -0.01196750346571207, -0.20922230184078217, 0.015256505459547043, 0.0058524589985609055, -0.1305825561285019, 0.13644491136074066, -0.11771459132432938, -0.004586963448673487, 0.03990330919623375, -0.01733347587287426, 0.051951587200164795, -0.15583574771881104, -0.009428007528185844, -0.06801126152276993, -0.059507038444280624, 0.10076519101858139, -0.3335290551185608, 0.10515650361776352, 0.025340037420392036], "changes": {"1wk": -8.237544935281228, "1mo": 2.298857609567729}}, {"text": "PREMIUM Bioventus Sells Advanced Rehabilitation Business to Accelmed Partners MT Newswires Thu, Jan 2, 2025, 5:13 PM In diesem Artikel: BVS Bioventus (BVS) said Thursday it has divested its Advanced Rehabilitation business under its Bioness PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Hochstufung Sie haben bereits ein Abonnement? Jetzt anmelden AGB und Datenschutzerkl\u00e4rung Privacy Dashboard Empfohlene Nachrichtenartikel", "symbol": "BVS", "date": "2025-01-02T17:13:50", "sentiment": {"score": 0.03432726860046387, "confidence": 0.05343484878540039, "probabilities": {"positive": 0.05343484878540039, "negative": 0.019107580184936523, "neutral": 0.9274575710296631}}, "embedding": [-0.07112277299165726, -0.0018059236463159323, 0.01516707893460989, -0.029746580868959427, -0.0008895063656382263, 0.07249167561531067, -0.03371305763721466, 0.05973006784915924, -0.03395095840096474, -0.011006669141352177, 0.006369469221681356, 0.07547808438539505, -0.01102705392986536, 0.07321888953447342, -0.01597389578819275, 0.049524981528520584, 0.08598893135786057, -0.004820242989808321, -0.05645862594246864, 0.1031835600733757, -0.05569744482636452, 0.06722042709589005, 0.09210409969091415, 0.04350484907627106, -0.0473925918340683, 0.03128134086728096, -0.13152557611465454, 0.02539188228547573, 0.13464389741420746, -0.05716855078935623, -0.02950231544673443, 0.0458398312330246, 0.14688481390476227, -0.1257561296224594, 0.10781001299619675, 0.06782764941453934, -0.14955630898475647, -0.007200644817203283, -0.11373703181743622, 0.012319845147430897, -0.01537955179810524, -0.13721396028995514, -0.195685476064682, -0.023864805698394775, 0.05420323833823204, 0.023711219429969788, -0.07224550098180771, -0.11846870183944702, 0.08843070268630981, -0.04452528432011604, -0.025241855531930923, -0.10735572129487991, 0.12882554531097412, -0.01355309970676899, -0.08241814374923706, -0.06200326606631279, -0.14149513840675354, -0.03813452646136284, 0.029418865218758583, -0.15191195905208588, 0.17387524247169495, 0.029322924092411995, 0.028254982084035873, 0.08379655331373215, -0.05821912735700607, 0.03346357122063637, -0.008031778037548065, 0.0535053014755249, -0.030569011345505714, -0.17853528261184692, -0.005067396908998489, -0.1662914752960205, -0.005093117710202932, 0.005203552544116974, -0.012279256246984005, 0.21564532816410065, 0.11791573464870453, -0.0007616246002726257, 0.06374122947454453, -0.16879995167255402, 0.02544821798801422, -0.11498436331748962, -0.016169100999832153, 0.11738570034503937, -0.07136163115501404, 0.07510766386985779, -0.09711292386054993, -0.07543542236089706, 0.0015841819113120437, -0.02895321138203144, 0.04592123627662659, -0.04182695969939232, 0.0634937658905983, -0.14868751168251038, -0.03778752684593201, -0.03198283538222313, -0.15720531344413757, -0.06748684495687485, 0.010482470504939556, -0.04821131005883217, -0.04208919778466225, 0.06392665207386017, -0.02104913629591465, 0.061509836465120316, -0.045327458530664444, -0.13726317882537842, -0.03348717838525772, 0.084321528673172, 0.2715469300746918, 0.0431077741086483, 0.08333829790353775, 0.1721571683883667, 0.05482715368270874, -0.01274859718978405, 0.005542280152440071, 0.25516143441200256, -0.1809338629245758, -0.03797581419348717, 0.12808063626289368, -0.05617181211709976, 0.09247194230556488, 0.007301674224436283, 0.057869572192430496, -0.14985103905200958, -0.015111842192709446, -0.08174093067646027, 0.02415705844759941, 2.2484589986931842e-32, 0.0012866962933912873, -0.03802531957626343, -0.023709559813141823, -0.01191985234618187, 0.02546551078557968, 0.0006325746071524918, -0.039330482482910156, -0.20936743915081024, -0.05904635787010193, -0.06801492720842361, -0.2001359909772873, 0.18706193566322327, 0.09423917531967163, 0.18218204379081726, -0.012053103186190128, -0.11910954117774963, -0.1357431858778, 0.04752252250909805, 0.07290513068437576, 0.02847694233059883, 0.12868933379650116, -0.05649072676897049, 0.04905705899000168, 0.0416904091835022, 0.06702160090208054, 0.020736325532197952, 0.04832190275192261, 0.05467178300023079, 0.1254676729440689, 0.08519568294286728, -0.07886099815368652, 0.01259174756705761, -0.15110044181346893, -0.1633625328540802, -0.06724351644515991, 0.04216167703270912, 0.00795623380690813, -0.09149126708507538, -0.08886818587779999, -0.04442870244383812, 0.04816563054919243, 0.016239328309893608, -0.08219034969806671, -0.11473347246646881, 0.020635873079299927, -0.027396950870752335, 0.023441877216100693, -0.11372095346450806, 0.09328353404998779, -0.006142958998680115, -0.08120878040790558, 0.021081339567899704, 0.03223266080021858, -0.20876875519752502, -0.058227475732564926, -0.01697790063917637, -0.05779923126101494, 0.02042192593216896, 0.11437767744064331, 0.0677841305732727, 0.1353238821029663, 0.17193494737148285, -0.0011212192475795746, 0.054985783994197845, -0.0465879887342453, 0.052418794482946396, 0.029233770444989204, -0.00292700482532382, -0.13039927184581757, -0.039403486996889114, 0.03168647363781929, -0.021932024508714676, 0.017746010795235634, -0.12670902907848358, -0.05570695921778679, 0.008836311288177967, -0.13064995408058167, 0.048755887895822525, -0.07283660024404526, -0.021914763376116753, -0.050623394548892975, -0.028673388063907623, 0.031816549599170685, 0.07891203463077545, 0.14303208887577057, 0.03556859493255615, -0.006920164916664362, -0.0682222917675972, -0.009918872267007828, -0.02907925844192505, -0.024797499179840088, 0.005886203609406948, -0.10236520320177078, 0.21004118025302887, -0.0967072993516922, -2.3529166593167174e-32, -0.08586911857128143, 0.006230813451111317, 0.036814309656620026, -0.027929866686463356, 0.0332803800702095, 0.002350572729483247, 0.009623417630791664, 0.06547310948371887, 0.02721632458269596, 0.04704291746020317, 0.00989708211272955, 0.09673556685447693, -0.12444578856229782, 0.0667245090007782, 0.07139980047941208, 0.09040402621030807, -0.015335145406425, -0.05410505086183548, -0.1339988112449646, 0.047064512968063354, 0.06829153746366501, 0.22326797246932983, 0.03131254017353058, 0.06650883704423904, 0.0638587698340416, 0.0631125345826149, 0.04246256500482559, 0.14960850775241852, 0.04794107750058174, -0.12706442177295685, -0.05110704153776169, 0.03337714821100235, -0.21130502223968506, 0.10455677658319473, -0.019734304398298264, 0.03384833782911301, 0.07251003384590149, -0.07559265941381454, 0.0015812991186976433, -0.14024537801742554, 0.13249030709266663, -0.03050260618329048, -0.26295405626296997, 0.04453771933913231, 0.10287272185087204, 0.005915455985814333, -0.07827173173427582, -0.11824779212474823, 0.14826203882694244, 0.02212923765182495, 0.05480515956878662, 0.030502723529934883, 0.12202582508325577, 0.08788643777370453, 0.0351809598505497, -0.07983911037445068, 0.06243697553873062, 0.005516386590898037, -0.13913333415985107, -0.020711297169327736, 0.05635451525449753, 0.08614791929721832, -0.01437388639897108, -0.008137430064380169, 0.08387503772974014, 0.22060488164424896, 0.10347975790500641, 0.023171449080109596, -0.1031898558139801, -0.1251598447561264, 0.033649567514657974, 0.01892344281077385, -0.14398589730262756, -0.1521063894033432, -0.04300514608621597, 0.17748518288135529, -0.06338505446910858, -0.10705364495515823, -0.1134975254535675, -0.04619530588388443, 0.026610152795910835, -0.14707180857658386, 0.1311757117509842, -0.061003852635622025, 0.03146039694547653, -0.08209265768527985, -0.11713582277297974, -0.07479277998209, -0.009218543767929077, 0.0158698707818985, -0.1293550282716751, -0.15013638138771057, -0.02553234063088894, 0.11214516311883926, 0.028133565559983253, -1.0131811478686359e-07, 0.0565183199942112, 0.01560510415583849, 0.055645816028118134, 0.04335255175828934, 0.09578688442707062, -0.1404632329940796, -0.11060923337936401, 0.021767186000943184, -0.0007522479863837361, 0.058006688952445984, -0.09370818734169006, -0.11480959504842758, 0.0010516343172639608, 0.13167205452919006, 0.07858344167470932, 0.09785464406013489, -0.06618284434080124, 0.15761633217334747, -0.05751251429319382, -0.08962993323802948, 0.03487272188067436, -0.07122065871953964, 0.13701488077640533, -0.046569760888814926, 0.04229136183857918, -0.07549090683460236, -0.06956586986780167, -0.11256987601518631, 0.131707563996315, -0.09559492766857147, 0.02680687978863716, 0.14134865999221802, 0.010966256260871887, 0.05203024670481682, 0.00773786474019289, -0.12712885439395905, 0.021873414516448975, 0.04151206091046333, -0.051787592470645905, 0.041895605623722076, -0.12176109850406647, -0.14541253447532654, 0.01723211444914341, 0.022636285051703453, -0.008204758167266846, 0.021027982234954834, -0.17347480356693268, -0.09144926071166992, 0.06915560364723206, -0.025149786844849586, 0.10206852108240128, -0.13586504757404327, 0.10745038837194443, 0.019643891602754593, -0.125833660364151, 0.06295803189277649, 0.03876620531082153, -0.07883270829916, -0.00937817431986332, -0.025523751974105835, 0.10109980404376984, -0.1491929590702057, 0.18181447684764862, -0.09327664971351624], "changes": {"1wk": -9.877706297560918, "1mo": 0.47036867541457245}}]